Porcine Sapelovirus

Overview and Taxonomy of Porcine Sapelovirus

Porcine sapelovirus (PSV) represents a globally ubiquitous and economically significant pathogen of swine, classified within the family Picornaviridae, genus Sapelovirus [36]. The virus is associated with a broad spectrum of clinical manifestations, including acute diarrhea, respiratory distress, polioencephalomyelitis, reproductive failure (comprising the SMEDI syndrome, stillbirth, mummification, embryonic death, and infertility), and skin lesions [1, 2, 5, 8, 9, 12]. Despite its widespread distribution and high prevalence in pig populations worldwide, PSV has historically been considered an understudied pathogen, with much of its biology, pathogenesis, and evolutionary dynamics only recently being elucidated through advanced molecular and genomic techniques [13, 19, 36]. The virus is particularly noted for its remarkable stability in the environment, facilitating facile fecal-oral transmission within and between herds, and its ability to replicate in a variety of cell lines of porcine origin, which has been instrumental in its isolation and characterization [8, 13, 20, 29].

Taxonomic Classification and Phylogenetic Placement

The genus Sapelovirus is one of the many genera within the highly diverse family Picornaviridae, a family of small, non-enveloped, positive-sense single-stranded RNA viruses [16, 29, 30, 46]. Historically, PSV was grouped with porcine teschoviruses (PTV) and porcine enterovirus G (EV-G) under the umbrella term "porcine enteroviruses," but advances in molecular phylogenetics led to their reclassification into distinct genera based on significant genetic divergence, particularly within the capsid-encoding regions [26, 28, 34, 42]. The genus Sapelovirus currently includes PSV (formally designated Sapelovirus A), as well as sapeloviruses identified in other hosts such as non-human primates, birds, and other mammals [30, 36]. However, PSV remains the most extensively characterized member due to its direct impact on swine health and production [4, 31, 36].

Initial classification efforts, based largely on serological cross-reactivity and limited genetic data, considered PSV to comprise a single genotype [16]. This perspective was challenged by the discovery of highly divergent strains that did not fit neatly into this monotypic framework. The seminal work of Yang et al. (2021) provided a robust, sequence-based genotype definition for PSV, establishing clear cut-off values for demarcation [16]. Through comprehensive phylogenetic and genetic distance analyses of the polyprotein, P1 (structural protein precursor), and VP1 genes from all available PSV sequences, two distinct genotypes were formally proposed: PSV-1 and PSV-2 [16]. The established cut-off values for genotype definition are 0.1115 (number of differences per site) for the polyprotein, 0.176 for the P1 region, and crucially, 0.272 for the highly variable VP1 gene [16]. This VP1-based cut-off is particularly important because VP1 is the primary surface-exposed protein and the major determinant of serotype, analogous to other picornaviruses [11, 42].

The global PSV population is overwhelmingly dominated by strains belonging to the PSV-1 genotype [3, 14, 31]. This genotype is further subdivided into numerous lineages and sub-lineages, often reflecting geographic clustering. For instance, Chinese PSV isolates frequently form a distinct "China clade," while strains from the Americas, Europe, and Africa often segregate into other branches within PSV-1 [2, 5, 6, 10, 13, 15, 35, 37]. Within PSV-1, significant intra-genotypic diversity exists, with at least three distinct lineages (Lineages 1, 2, and 3) identified among Zambian strains, each showing differential replication kinetics in cell culture [40]. Similarly, Italian strains have demonstrated high heterogeneity, with sequences from a single farm clustering into three distinct clades, indicating the potential for co-circulation of multiple distinct viral variants within a single production system [21]. A potentially novel or second genotype (PSV-2) was proposed following the characterization of strain SZ1M-F/PSV/HUN2013 from a paraplegic pig in Hungary [33]. This strain exhibited only 64% nucleotide identity in the VP1 region to its closest PSV-1 relative, well below the established cut-off for genotype classification [33]. The existence of this divergent strain, alongside evidence from Ukrainian studies that identified a strain reclassified as a new genotype of Sapelovirus A (strain Ch 881), suggests that the genetic diversity of PSV is greater than previously recognized and that additional genotypes may be circulating, particularly in regions with less intensive surveillance [33, 34, 39].

Genomic Organization and Key Structural Features

The PSV genome is a single-stranded, positive-sense RNA molecule of approximately 7.5–7.6 kilobases in length, excluding the 3’ poly(A) tail [2, 8, 15, 20, 29]. Its organization is typical of members of the family Picornaviridae: a 5’ untranslated region (UTR) containing an internal ribosome entry site (IRES), followed by a single large open reading frame (ORF) that is translated into a polyprotein precursor, and a short 3’ UTR preceding the poly(A) tail [20, 29]. The polyprotein is co- and post-translationally cleaved by viral proteases (primarily 3Cpro) into functional proteins in the order: L (leader protein) - VP4 - VP2 - VP3 - VP1 - 2A - 2B - 2C - 3A - 3B (VPg) - 3Cpro - 3Dpol [20, 29]. The structural proteins (VP1-VP4) form the icosahedral capsid, with VP1, VP2, and VP3 exposed on the surface and VP4 located internally, associated with the RNA core [20]. The molecular masses of VP1, VP2, VP3, and VP4 are approximately 35, 26, 25, and 6 kDa, respectively [20]. The cleavage sites between these capsid proteins have been confirmed as Lys/Ala for VP4/VP2, and Gln/Gly for both VP2/VP3 and VP3/VP1 [20].

The 5’ UTR is a highly structured region crucial for cap-independent translation initiation and contains a type-IV IRES element [29]. Within the coding region, three distinct cis-acting RNA elements have been identified: the IRES, a cis-replication element (CRE) located within the 2C coding region, and the 3’ UTR [29]. Interestingly, the structural features of the CRE and 3’ UTR have been shown to vary among different PSV strains, suggesting potential differences in replication efficiency or host range [29]. The 3Dpol gene encodes the RNA-dependent RNA polymerase (RdRp), a highly conserved enzyme essential for viral genome replication and a common target for molecular diagnostics [4, 18, 23]. The 2A and 3C proteins are proteases that mediate polyprotein processing. The 3Cpro is a chymotrypsin-like cysteine protease with dual roles: processing the viral polyprotein and cleaving host proteins to antagonize the innate immune response, notably by targeting mitochondrial antiviral signaling (MAVS), melanoma differentiation-associated gene 5 (MDA5), and TANK-binding kinase 1 (TBK1) to inhibit type I interferon production [9]. The 2A protein is another critical viral factor, recently shown to induce mitochondria-dependent apoptosis in infected cells, with its conserved protease residues H48, D91, and C164 being essential for this pro-apoptotic function [12].

Evolutionary Dynamics and Host Adaptation

PSV, like all RNA viruses, is characterized by a high mutation rate due to the lack of proofreading activity of its RdRp, a feature that drives rapid genetic diversification [3, 14, 17]. This is compounded by the common occurrence of homologous recombination, which acts as a powerful force in shaping viral genomes and generating novel strains [2, 5, 6, 15, 31, 40]. Recombination breakpoints are frequently identified in the genomic regions encoding the leader protein (L), the 2A protein, and the VP1-2A junction, among others [5, 6, 40]. For instance, strain PSV2020 from Fujian, China, exhibited a potential recombination signal near the 3’ end of VP1 [5], while strain PSV-ML-19 from Yunnan was identified as a possible recombinant between a major parent from China and a minor parent from Germany [2]. Similarly, the Korean strain PSV/Goryeong/KR-2019 was predicted to result from recombination between a Korean and a Japanese strain [31]. This propensity for recombination, combined with high mutation rates, results in substantial genetic diversity, particularly within the hypervariable regions of the VP1-encoding gene [2-5].

Codon usage bias analysis of the PSV polyprotein gene has provided valuable insights into the virus’s evolutionary dynamics and host adaptation [17]. The overall nucleotide composition is adenine-rich, with a distinct preference for thymine at the third codon position [17]. Analysis of relative synonymous codon usage and effective number of codons reveals that natural selection, rather than mutational pressure, is the dominant force shaping codon usage bias in PSV [17]. The relatively low Codon Adaptation Index (CAI = 0.584) suggests a moderate adaptation to its primary host, Sus scrofa domesticus, implying evolutionary constraints on translational efficiency and ongoing co-evolution with the porcine host [17]. Furthermore, strong negative selection (purifying selection) acts upon the VP1 gene, as evidenced by a very low average dN/dS ratio (0.0838), indicating that most non-synonymous mutations are deleterious and removed from the population to preserve critical capsid functions [3]. However, specific sites within VP1, such as the 95th amino acid, have been identified as being under positive selection, suggesting that immune pressure from the host drives adaptive changes at crucial antigenic epitopes [3]. This interplay of strong purifying selection and targeted positive selection allows PSV to maintain its fundamental structure while evading host immunity.

Global Distribution and Implications for Pathogen Control

The ubiquity of PSV is underscored by its detection in swine populations across all inhabited continents, including Asia [1-3, 5, 13, 14, 19, 24], Europe [21, 22, 27, 28, 33, 37], Africa [40], North America [25, 35, 38], South America [26], and Australia [45]. Its role as a primary or contributing agent in porcine diarrhea, respiratory disease, and neurological syndromes has been increasingly recognized, particularly in the context of complex co-infections with other enteric pathogens such as porcine epidemic diarrhea virus (PEDV), porcine deltacoronavirus (PDCoV), porcine kobuvirus (PKoV), and porcine rotavirus (PoRV) [1, 3, 6, 7, 32, 38, 41, 44]. The high prevalence of PSV in both healthy and diseased pigs complicates the establishment of a definitive causal link between infection and clinical disease, but the virus is now widely accepted as a significant contributor to the multifactorial disease complexes that plague the global swine industry [28, 31, 36]. The virus’s remarkable stability in feed ingredients under simulated transboundary shipping conditions highlights its potential for international spread via contaminated animal feed, posing a significant risk to disease-free regions [43]. While PSV is not currently a WOAH (World Organisation for Animal Health)-listed disease, the economic burden it imposes, through direct mortality, reduced growth performance, and the costs associated with diagnostic differentiation and control, is substantial and warrants its recognition as a critical pathogen for global swine health surveillance and research.

Virion Structure and Genome Organization of Porcine Sapelovirus

Porcine sapelovirus (PSV), classified within the genus Sapelovirus of the family Picornaviridae, represents an archetypal non-enveloped, icosahedral virus with a single-stranded, positive-sense RNA genome. As an emerging pathogen of global significance in swine production, PSV is associated with a spectrum of clinical manifestations ranging from subclinical enteric infections to severe polioencephalomyelitis, respiratory distress, and reproductive failure [1, 36]. The structural and genomic architecture of PSV provides a foundational framework for understanding its replication strategy, host cell interactions, evolutionary plasticity, and the molecular determinants of pathogenesis. A comprehensive dissection of the virion properties and genomic organization is therefore essential for informing diagnostic approaches, vaccine development, and epidemiological surveillance strategies.

Physicochemical Properties and Virion Morphology

PSV virions exhibit the canonical picornavirus morphology: spherical, non-enveloped particles with an icosahedral symmetry. Transmission electron microscopy (TEM) of purified PSV particles from cell culture supernatants reveals a diameter of approximately 25 to 35 nm, with multiple independent studies consistently reporting measurements of ~32 nm [2, 8] and 25–35 nm across diverse geographical isolates [13, 20, 24]. This size variation may reflect minor differences in preparation methods or the presence of both mature virions and empty capsid intermediates. Notably, ultracentrifugation analysis of PSV particles isolated from PLC/PRF/5 cell cultures has identified two distinct populations of virus particles with identical diameters but differing buoyant densities: 1.300 g/cm³ and 1.285 g/cm³ [20]. These species likely correspond to complete, infectious virions (containing the RNA genome) and empty or immature particles lacking nucleic acid, a phenomenon observed in other picornaviruses. The dense, infectious particles are also referred to as “full” particles, while the lighter particles are “empty” capsids that may represent assembly intermediates or non-infectious byproducts of replication.

The virion capsid is composed of 60 copies each of four structural proteins, VP1, VP2, VP3, and VP4, arranged in an icosahedral shell with a T=1 (pseudo T=3) symmetry. In PSV, the molecular masses of these capsid proteins have been experimentally determined: VP1 at approximately 35 kDa, VP2 at 26 kDa, VP3 at 25 kDa, and VP4 at 6 kDa [20]. These values are consistent with the processing of a polyprotein precursor and align with the general picornaviral paradigm. The external surface of the virion is dominated by VP1, VP2, and VP3, which form the major antigenic determinants, while VP4 is located internally, associated with the RNA core. The viral capsid is notably resistant to environmental insults, including acidic pH and moderate heat; however, PSV infectivity is completely abolished by heating at 60°C for 10 minutes or at 65°C for 5 minutes [20]. Furthermore, exposure to 62.5 ppm of sodium hypochlorite (NaClO) for 30 minutes effectively inactivates the virus [20], underscoring its susceptibility to standard disinfectants. Such stability data have practical implications for biosecurity protocols in swine facilities and for the safety of animal-derived products. Indeed, PSV has been utilized as a surrogate for certain high-consequence pathogens in transboundary feed ingredient shipping models, where its survival kinetics under simulated transport conditions were evaluated [43].

The capsid surface topology is critical for host cell recognition. PSV utilizes α2,3-linked sialic acid moieties present on the GD1a ganglioside as a primary attachment receptor [47]. This interaction is highly specific; the virus does not bind histo-blood group antigens (HBGAs) in vitro [47]. The ganglioside GD1a is enriched in porcine cells, which may partially explain the species tropism of PSV. Following receptor engagement, PSV entry into susceptible cells proceeds via caveolae-dependent endocytosis, a process that requires low pH, dynamin activity, and the endosomal trafficking proteins Rab7 and Rab11 [48, 50]. This entry pathway has been confirmed in both PK-15 cells and the porcine small intestinal epithelial cell line IPEC-J2 [48, 50]. The endocytic route is clathrin-independent and macropinocytosis-independent, highlighting a distinct mechanism that is conserved across PSV strains. The structural features of the capsid that govern receptor binding and endocytic triggering remain areas of active investigation, but the VP1 protein is heavily implicated in these early steps, as its surface-exposed loops are known to contain critical receptor-binding sites.

Genome Architecture and Organization

The PSV genome is a non-segmented, single-stranded, positive-sense RNA molecule ranging in length from approximately 7,480 to 7,572 nucleotides (excluding the 3′ poly(A) tail) [2, 5, 8, 14, 15, 20, 24, 29]. Variations in genome length among different isolates (e.g., 7,480 nt for Chinese strains [2], 7,542–7,566 nt for Korean strains [29], 7,551 nt for the HaN01-CH2019 strain [24], and up to 7,572 nt for some isolates [8]) reflect the inherent genetic diversity and indel events within the non-coding regions and the hypervariable VP1 gene. The 5′ terminus of the RNA lacks a cap structure; instead, it is covalently linked to a small virus-encoded protein called VPg (3B), which is essential for priming RNA synthesis. The 3′ terminus features a polyadenylated tail, a hallmark of picornavirus genomes that is required for genome stability and translation initiation [20, 29].

The genome organization follows the universal picornavirus layout: 5′ untranslated region (5′UTR) – Leader (L) protein – P1 (structural) region encoding VP4, VP2, VP3, and VP1 – P2 (non-structural) region encoding 2A, 2B, and 2C – P3 (non-structural) region encoding 3A, 3B (VPg), 3C (protease), and 3D (RNA-dependent RNA polymerase) – 3′ untranslated region (3′UTR) – poly(A) tail [20, 29]. A single large open reading frame (ORF) spans nearly the entire genome, encoding a polyprotein of approximately 2,326 amino acids (in the related sapelo-like virus [30]; PSV polyproteins are of comparable size). This polyprotein is co- and post-translationally cleaved by virus-encoded proteases, primarily the 3C protease (3Cpro), to yield mature structural and non-structural proteins. The processing junctions have been experimentally determined: the cleavage sites between VP4 and VP2, VP2 and VP3, and VP3 and VP1 are K/A, Q/G, and Q/G, respectively [20]. These dipeptide motifs are conserved among sapeloviruses and dictate the sequential proteolytic maturation of the capsid.

5′ Untranslated Region (5′UTR) and Cis-Active RNA Elements

The 5′UTR of PSV is a highly structured RNA segment of substantial length (typically several hundred nucleotides) that plays a pivotal role in cap-independent translation initiation and genome replication. It contains a type IV internal ribosome entry site (IRES), a characteristic feature of picornaviruses in the Enterovirus/Sapelovirus supergroup [29, 30]. The IRES folds into a complex secondary and tertiary structure comprising multiple stem-loops that direct the recruitment of the 40S ribosomal subunit directly to the initiation codon, bypassing the need for cap-binding proteins. Bioinformatic predictions have identified conserved structural domains within the PSV 5′UTR that are essential for IRES activity [29]. Additionally, the 5′UTR may contain cis-acting replication elements (CREs) involved in the initiation of negative-strand RNA synthesis. The high conservation of the 5′UTR across PSV strains has made it a preferred target for molecular diagnostic assays, including TaqMan-based real-time PCR and RT-LAMP, due to its reliability for detection across diverse genotypes [1, 7, 23, 49].

Leader (L) Protein

Immediately downstream of the 5′UTR, the ORF begins with the leader (L) protein. The L protein is a small polypeptide that is unique to certain picornavirus genera and is present in sapeloviruses. In PSV, the L protein is approximately 68 amino acids in length [30], although its precise function remains less well-characterized compared to the L proteins of aphthoviruses (e.g., FMDV) or cardioviruses. The L protein may play a role in antagonizing host innate immune responses or modulating cellular translation. Its presence distinguishes the genome organization of sapeloviruses from enteroviruses, which lack an L protein. Recombination breakpoints have been mapped to the L coding region in some PSV strains, implicating this region in viral evolution and the generation of novel chimeric genomes [40].

Structural Protein Region (P1): VP4, VP2, VP3, and VP1

The P1 region encodes the four capsid proteins that form the mature virion. VP4 is the smallest, internally located, myristoylated protein, which lines the inner surface of the capsid and interacts with the viral RNA. The remaining three structural proteins, VP2, VP3, and VP1, form the external capsid shell. VP1 is the most variable and immunodominant of the structural proteins and is a key target for serotype classification and genotype definition [3, 16]. Indeed, VP1 gene sequencing is the standard for molecular typing of PSV, and genetic diversity within VP1 is used to delineate the two recognized genotypes: PSV-1 and PSV-2 [16]. The VP1 coding region displays hypervariability, particularly within surface-exposed loops, which is driven by immune selection pressure [3]. In Chinese PSV strains, the VP1 gene is under strong negative selection (average dN/dS = 0.0838), but specific residues (e.g., the 95th amino acid) are under positive selection, indicating that adaptive changes are concentrated at key antigenic sites [3]. Amino acid insertions have also been reported in VP1; for instance, strain PSV2020 from Fujian Province possesses a four-amino-acid insertion (STAE) at positions 898–902 AAs in the VP1 coding sequence [5]. Such insertions may alter capsid surface topology and potentially influence receptor binding or antibody escape.

The VP1 protein has been exploited for diagnostic purposes. Monoclonal antibodies (MAbs) generated against recombinant PSV VP1 have defined two linear B-cell epitopes: an immunodominant conserved epitope ²⁰³YDGDG²⁰⁷ recognized by MAb 15E4, and a strain-variable epitope ⁸QAIVNRT¹⁴ recognized by MAb 9F10 [11]. The conserved epitope is present across different PSV genotypes, making it a promising target for pan-PSV serological assays. Structural modeling confirms that both epitopes are located on the exposed surface of the capsid [11]. Furthermore, VP1 has been employed as a coating antigen for the development of an indirect ELISA for detecting PSV antibodies in swine serum, with reported positivity rates as high as 79.3% in field samples from China [8].

Non-Structural Protein Regions (P2 and P3)

The P2 and P3 regions encode seven non-structural proteins that orchestrate viral replication, polyprotein processing, and host immune evasion.

2A Protein: The 2A protein of PSV is a multifunctional polypeptide that has been characterized as a key inducer of mitochondrial-dependent apoptosis in infected cells [12]. PSV 2A possesses protease activity; conserved residues H48, D91, and C164 are critical for both its enzymatic function and its ability to trigger the intrinsic apoptotic pathway [12]. This apoptosis may facilitate viral dissemination or modulate the host inflammatory response. Furthermore, the 2A coding region is a hotspot for recombination, evidenced by detection of recombination signals near the 3′ end of the VP1/2A junction in several Chinese isolates [5].

2B and 2C Proteins: 2B and 2C are involved in membrane rearrangement and the formation of replication complexes. The 2C protein contains helicase and ATPase motifs and is essential for RNA replication. A cis-replication element (CRE) has been identified within the 2C coding region of PSV, positioned as a stem-loop structure that serves as a template for the uridylylation of VPg (3B) during the initiation of RNA synthesis [29]. The presence of this CRE is typical of picornaviruses, but its specific structure in PSV may differ between strains, potentially influencing replication efficiency.

3A, 3B (VPg), 3C (Protease), and 3D (RNA-dependent RNA Polymerase): The P3 region encodes the proteins responsible for genome replication and polyprotein processing. 3A is a membrane-anchoring protein that tethers the replication complex to intracellular membranes. 3B is the VPg protein that primes RNA synthesis. The 3C protease is a chymotrypsin-like cysteine protease that cleaves the polyprotein at defined dipeptide junctions (including Q/G and K/A) and also degrades host innate immune signaling molecules. Specifically, PSV 3Cpro inhibits the production of type I interferon (IFN-β) by cleaving mitochondrial antiviral signaling protein (MAVS) and by degrading melanoma differentiation-associated gene 5 (MDA5) and TANK-binding kinase 1 (TBK1) through its protease activity [9]. This immune evasion strategy allows PSV to establish infection despite host antiviral defenses. The 3D protein is the RNA-dependent RNA polymerase (RdRp) that synthesizes both negative- and positive-strand RNA. The 3D coding region, like VP1, has been used as a target for molecular detection and phylogenetic analysis [18]. The 3AB protein (a precursor of 3A and 3B) has been developed as a DIVA (differentiating infected from vaccinated animals) diagnostic antigen; an indirect ELISA using recombinant 3AB shows 99.78% sensitivity and 100% specificity for detecting antibodies in infected pigs versus vaccinated animals [4].

3′ Untranslated Region (3′UTR) and Poly(A) Tail

The 3′UTR of the PSV genome is relatively short but forms conserved secondary structures that are important for RNA replication. The 3′UTR interacts with viral and host proteins to recruit the replication machinery and ensure efficient negative-strand synthesis. The poly(A) tail is encoded within the viral genome and is not added post-transcriptionally; it is required for both translation and genome stability. Structural predictions of the 3′UTR in different PSV strains reveal heterogeneity, suggesting that this region may contribute to strain-specific replication dynamics [29].

Genetic Diversity, Genotypes, and Evolutionary Dynamics

Phylogenetic analyses of the complete polyprotein, P1 region, and VP1 gene have consistently supported the division of PSV into at least two distinct genotypes: PSV-1 and PSV-2 [16]. The current genotype definition, based on pairwise amino acid sequence distances, establishes cut-off values of 0.1115 for the polyprotein, 0.176 for P1, and 0.272 for VP1 to distinguish genotypes [16]. Most globally circulating strains, including those from China, Korea, India, Europe, and North America, belong to PSV-1 [3, 14, 19, 21, 25]. A potentially novel genotype (PSV-2) has been proposed based on a Hungarian strain (SZ1M-F/PSV/HUN2013) that shares only 64% nucleotide identity in VP1 with PSV-1 strains [33]. This genotype may have emerged through recombination events [33]. Indeed, recombination is a major driver of PSV evolution, with breakpoints frequently identified in the L, 2A, and 2C regions [5, 6, 15, 31, 40]. Codon usage bias analysis reveals that natural selection is the predominant force shaping PSV polyprotein evolution, with mutational pressure playing a secondary role [17]. The codon adaptation index (CAI = 0.584) indicates moderate adaptation of PSV to its natural host, Sus scrofa domesticus, suggesting ongoing evolutionary optimization for translational efficiency [17]. This genomic plasticity presents challenges for vaccine design and underscores the need for continuous molecular surveillance.

Molecular Pathogenesis and Genetic Diversity of Porcine Sapelovirus

Porcine sapelovirus (PSV), a member of the genus Sapelovirus within the family Picornaviridae, represents a ubiquitous and economically significant pathogen of swine worldwide. The virus is associated with a remarkably broad spectrum of clinical manifestations, including acute diarrhea, respiratory distress, polioencephalomyelitis, reproductive failure (often subsumed under the SMEDI syndrome, stillbirth, mummification, embryonic death, and infertility), and skin lesions [2, 3, 5, 8]. Despite its global distribution and high prevalence in pig herds, the precise molecular mechanisms governing PSV pathogenesis, its cellular tropism, and the forces driving its extensive genetic diversity are areas of intense and ongoing investigation. This section provides an exhaustive analysis of the molecular pathogenesis of PSV, detailing the viral life cycle, host-virus interactions at the cellular and molecular levels, and the intricate genetic landscape that underpins its evolution and global dissemination.

Molecular Basis of Viral Entry and Cellular Tropism

The initial steps of PSV infection are dictated by its interaction with host cell surface receptors. Seminal work by Kim et al. [47] elucidated that PSV utilizes α2,3-linked sialic acid (SA) present on the ganglioside GD1a as a primary receptor for attachment and entry. This was demonstrated through a series of elegant experiments showing that enzymatic removal of α2,3-linked SA with linkage-specific sialidases, or competitive inhibition with GD1a, abrogated viral binding and infection. Intriguingly, PSV showed no affinity for histo-blood group antigens, highlighting the specificity of this interaction [47]. This receptor usage is a critical determinant of tissue tropism, as α2,3-linked SA is abundantly expressed on epithelial cells of the porcine intestinal tract and respiratory system, aligning with the primary sites of PSV replication and pathology.

Following receptor binding, PSV employs a sophisticated endocytic pathway to gain entry into host cells. Detailed studies in both PK-15 (porcine kidney) and IPEC-J2 (porcine intestinal epithelial) cells have demonstrated that PSV entry is dependent on caveolae/lipid raft-mediated endocytosis [48, 50]. This process is strictly pH-dependent, requiring a low-pH environment within endosomes, and is dependent on dynamin, a GTPase essential for scission of caveolar vesicles from the plasma membrane. Furthermore, the process requires phosphatidylinositol 3-kinase (PI3K) activity and is independent of clathrin-mediated endocytosis and macropinocytosis [48, 50]. Upon internalization, the virus is trafficked to late endosomes and recycling endosomes, a process requiring the small GTPases Rab7 and Rab11, before eventually releasing its genome into the cytoplasm for replication [48]. The specificity for porcine cells is underscored by findings that while PSV can bind to cultured cell lines from various species, productive replication occurs only in cells of porcine origin, suggesting the requirement for additional, porcine-specific intracellular factors beyond the sialic acid receptor [56]. Recent proteomic analyses have also identified host proteins that modulate PSV replication. Syndecan-1 (SDC1), a cell surface heparan sulfate proteoglycan, was shown to be significantly upregulated upon PSV infection and was required for efficient viral VP1 synthesis and viral titer, while its silencing markedly reduced replication [52]. This suggests that PSV co-opts SDC1 to facilitate a post-entry step in its life cycle, potentially enhancing viral assembly or egress.

Immune Evasion: Counteracting Host Innate Defenses

A hallmark of successful viral pathogenesis is the ability to subvert the host's innate immune response, particularly the type I interferon (IFN) system. PSV has evolved a multifaceted strategy to antagonize this critical antiviral pathway. Foundational studies by Yin et al. [9] demonstrated that PSV is sensitive to exogenous IFN-β, yet the virus is remarkably adept at blocking the induction of IFN-β mRNA expression. The primary weapon in this arsenal is the viral 3C protease (3Cpro). This non-structural protein acts at multiple nodes of the retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) signaling cascade. Specifically, PSV 3Cpro cleaves the crucial adaptor protein mitochondrial antiviral signaling protein (MAVS) via a caspase-dependent pathway, effectively severing the connection between upstream viral RNA sensors and downstream transcription factors [9]. Furthermore, 3Cpro promotes the degradation of both melanoma differentiation-associated gene 5 (MDA5) and TANK-binding kinase 1 (TBK1) through its own protease activity [9]. TBK1 is a central kinase responsible for phosphorylating and activating the transcription factors interferon regulatory factor 3 (IRF3) and IRF7, which are essential for IFN-β transcription. By simultaneously targeting MAVS, MDA5, and TBK1, PSV 3Cpro ensures a potent and redundant blockade of IFN-β production, allowing the virus to establish a robust infection in the face of host antiviral responses. This sophisticated level of immune evasion is a key factor in the virus's ability to cause systemic disease and persist within pig populations.

Induction of Host Cell Apoptosis

Beyond immune evasion, PSV infection triggers programmed cell death, or apoptosis, which can contribute to tissue pathology and viral dissemination. PSV infection in cell culture leads to classic morphological features of apoptosis, including nuclear condensation and fragmentation, and is accompanied by activation of caspases and cleavage of poly (ADP-ribose) polymerase 1 (PARP1) [12]. The viral 2A protein has been identified as the primary inducer of the mitochondrial (intrinsic) apoptotic pathway. Mechanistically, PSV 2A localizes to the mitochondria and triggers the release of cytochrome c, leading to the activation of the caspase cascade. The protease activity of 2A is absolutely critical for this function, as mutations in its conserved catalytic residues (H48, D91, C164) completely abrogate its ability to induce apoptosis [12]. The induction of apoptosis by PSV may serve a dual purpose: it eliminates infected cells, potentially contributing to the pathology of diarrhea and encephalitis, and it may also facilitate viral release and cell-to-cell spread while simultaneously dampening the inflammatory response associated with necrotic cell death.

Genetic Diversity and Global Epidemiology

The genetic landscape of PSV is characterized by remarkable diversity, driven by the error-prone nature of its RNA-dependent RNA polymerase, high mutation rates, and frequent recombination events. This genetic heterogeneity has profound implications for viral fitness, antigenicity, and the emergence of novel pathogenic strains.

Genomic Organization and Classification: The PSV genome is a single-stranded, positive-sense RNA molecule of approximately 7.5 to 7.6 kilobases, organized as a single open reading frame (ORF) flanked by 5' and 3' untranslated regions (UTRs) [2, 8, 29, 31]. The ORF encodes a large polyprotein that is cleaved into a leader protein (L), four structural proteins (VP4, VP2, VP3, and VP1) that form the icosahedral capsid, and seven non-structural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) involved in genome replication and host modulation [20, 29]. The VP1 capsid protein is the most variable and immunodominant region, making it the primary target for genotyping and phylogenetic analyses [3, 14, 19]. For decades, PSV was considered a single genotype. However, based on phylogenetic and genetic distance analyses of VP1, P1, and polyprotein sequences, a formal genotype definition has been proposed, delineating two distinct genotypes: PSV-1 (the classical genotype) and PSV-2 (a potentially novel genotype) [16]. The vast majority of circulating strains worldwide, including those from China, Korea, India, Europe, and Africa, belong to PSV-1 [3, 14, 31, 33]. A potentially novel genotype was identified in Hungary (strain SZ1M-F/PSV/HUN2013), which showed only 64% nucleotide identity in VP1 to the closest PSV-1 relative, highlighting the existence of highly divergent lineages [33].

Recombination as a Major Evolutionary Driver: Recombination is a pervasive and powerful force shaping PSV evolution. Numerous studies have identified recombination breakpoints scattered across the viral genome, most frequently in the non-structural protein coding regions (e.g., 2A, 2C, 3D) and the leader protein (L) [2, 5, 6, 15, 31, 40]. For example, the PSV-ML-19 strain from Yunnan, China, and the PSV/Goryeong/KR-2019 strain from Korea were both predicted to be recombinants between distinct parental strains [2, 31]. Similarly, the PSV2020 strain from Fujian, China, showed a clear recombination signal near the 3' end of VP1 and within the 2A region [5]. These recombination events can lead to the shuffling of antigenic determinants (e.g., VP1) and replication machinery (e.g., 3D), potentially generating viruses with altered virulence, host range, or immune escape capabilities. The identification of a potentially recombinant, novel PSV genotype in Hungary [33] and a Zambian isolate with a recombination breakpoint in the L and 2A genes [40] underscores the global and ongoing nature of this evolutionary process.

Global Geographic Distribution and Prevalence: PSV is endemic in swine populations across virtually all pig-producing regions of the world, including Asia, Europe, North America, Africa, and Australia [2, 5, 8, 19, 21, 25, 27, 33, 40]. Prevalence rates vary widely depending on the region, age of pigs, health status, and detection method, but consistently demonstrate a high burden of infection. In China, which has the world's largest swine herd, PSV is a major concern. Recent large-scale epidemiological surveys report positivity rates of 15.25% (278/1823) in Shanghai [1], 36.50% (592/1622) in Yunnan [3], and 30.8% (80/260) in Fujian [5]. In Europe, similarly high rates are observed, with 62.0% (563/908) of samples testing positive in Corsica, France [27], and detections in 97% (63/64) of grower fecal pools in an Italian farm [21]. In Switzerland, 51% of fecal samples from healthy pigs were PSV-positive [28]. In the United States, PSV was identified in 31% (67/217) of PEDV-positive diarrheic samples [38] and was the etiological agent of a severe polioencephalomyelitis outbreak in finishing pigs [35]. High prevalence is also reported in Africa, with a 94% positivity rate in fattening pigs in Zambia [40], and in India, where rates range from 7.14% to 23.3% [19, 44, 54, 55]. The virus is also detected in captive wild boars, indicating a broad reservoir in the suid population [26].

Phylogenetic Clustering and VP1 Hypervariability: Phylogenetic analyses consistently reveal that PSV strains cluster largely by geographic origin, with distinct clades corresponding to Chinese, Korean, Japanese, European, and North American isolates [2, 5, 6, 13, 15, 20, 29, 37, 40]. However, significant genetic admixture is apparent, reflecting the international movement of pigs and swine products. The VP1 gene is the most hypervariable region of the genome, and its diversity is a key driver of antigenic variation. For instance, the PSV2020 strain from Fujian had a surprising phylogenetic topology in VP1 that grouped it closer to an Italian strain (DIAPD5469-10) than to its Asian counterparts, a finding attributed to recombination [5]. Furthermore, a 12-nucleotide insertion in the VP1 gene of PSV2020 (encoding four amino acids, STAE) at positions 898–902 was observed, which is a rare but notable example of indel-driven diversity in a capsid protein [5]. This hypervariability is subject to strong purifying (negative) selection pressure overall, as evidenced by a low average dN/dS ratio of 0.0838 in Yunnan strains, indicating that most mutations are deleterious [3]. However, specific amino acid sites, such as the 95th amino acid in VP1, are under positive selection, suggesting that adaptive evolution at key residues is critical for immune escape or receptor binding [3].

Codon Usage and Host Adaptation: The evolutionary forces shaping PSV are not limited to nucleotide substitutions and recombination. A comprehensive analysis of codon usage bias in PSV revealed that natural selection is the dominant force driving codon usage patterns, with mutational pressure playing a lesser but significant role [17]. The virus shows moderate adaptation to its primary host, Sus scrofa domesticus, as measured by the codon adaptation index (CAI = 0.584), reflecting evolutionary constraints on translational efficiency within the porcine host [17]. The relative synonymous codon usage (RSCU) analysis identified overrepresented and underrepresented codons, suggesting that PSV has fine-tuned its codon usage to match the available tRNA pool of its host, optimizing protein synthesis and replication speed [17]. These insights into codon usage patterns provide a molecular-level view of host adaptation and viral fitness, complementing studies of viral protein function.

Clinical Implications and Pathological Correlates

The genetic diversity of PSV directly impacts its pathogenic potential. While many infections are subclinical, specific strains can cause severe disease. The link between genotype and virulence, however, remains complex. Experimentally, a Korean PSV strain (Goryeong/KR-2019) caused only mild diarrhea in suckling pigs and no neurological signs in older pigs, suggesting it is a weakly pathogenic strain [31]. Conversely, the GS01 strain from western China caused severe diarrhea and inflammatory responses in neonatal piglets [10]. Similarly, the HNHB-01 strain from Henan, China, exhibited broad tissue tropism and caused obvious clinical symptoms in 5-day-old piglets [6]. The molecular basis for these differences in virulence is likely multifactorial, involving variations in capsid proteins affecting receptor binding, mutations in non-structural proteins modulating immune evasion or replication efficiency, and recombination events that generate novel viral phenotypes. The detection of PSV in the central nervous system of pigs with severe polioencephalomyelitis, both in the USA [35] and in experimental infections [18, 51, 56], confirms the neurotropic potential of certain strains. Pathological lesions include perivascular cuffing, neuronophagia, and focal gliosis in the brain and spinal cord, alongside interstitial pneumonia and enteritis with villous atrophy [18, 51, 53, 55]. The ability of PSV to disseminate from the gut to extra-intestinal organs, as demonstrated in mouse models, further underscores its capacity to cause systemic disease [55].

The development of effective control strategies, including vaccines, is hampered by this genetic and antigenic diversity. The conserved nature of certain epitopes, such as the B cell epitope 203YDGDG207 on VP1, which is recognized by a monoclonal antibody and is conserved across PSV genotypes [11], offers a potential target for broadly cross-reactive diagnostic assays. However, for a broadly protective vaccine, understanding the spectrum of

Epidemiology and Prevalence of Porcine Sapelovirus in Swine Populations

Porcine sapelovirus (PSV) is now recognized as one of the most ubiquitous and genetically diverse enteric viruses circulating in global swine populations. Its epidemiological profile is characterized by high prevalence rates across virtually all pig-producing regions, a marked propensity for subclinical shedding, and a complex interplay with host age, production system, and co-infecting pathogens. The virus, a member of the genus Sapelovirus within the family Picornaviridae, has been detected on every continent where swine are raised, with prevalence rates ranging from approximately 7% to over 94% depending on the population sampled, diagnostic methodology employed, and geographic region [2, 3, 5, 8, 13, 14, 19, 21, 27, 28, 31, 40, 54]. This section provides a comprehensive, data-driven analysis of the global distribution, prevalence determinants, and epidemiological patterns of PSV infection, drawing upon extensive molecular surveillance studies conducted over the past two decades.

Global Distribution and Continental Prevalence Patterns

The global distribution of PSV is truly panzootic. The virus has been molecularly confirmed and genetically characterized in swine populations across Asia, Europe, North America, South America, Africa, and Australia [1, 2, 5, 8, 13, 14, 18, 19, 21, 22, 25-28, 31, 33, 35, 37, 40, 42, 45]. The earliest systematic isolations and molecular characterizations emerged from Europe and Asia, but the advent of high-throughput sequencing and metagenomics has dramatically expanded our understanding of its true geographic footprint. In Asia, particularly China, the epidemiological data are the most extensive, reflecting both the scale of the swine industry and the intensity of research activity. A landmark study by Li et al. (2019) utilizing a quadruplex RT-qPCR on 1,823 fecal samples from Chinese pig farms reported a PSV positivity rate of 15.25% [1]. However, this figure likely underestimates the true burden, as more recent and geographically focused studies have revealed substantially higher rates. For instance, a comprehensive survey in Yunnan Province, China, from 2024 to 2025, involving 1,622 fecal samples, documented an overall infection rate of 36.50%, with significant regional variation [3]. Even more striking, a study in Fujian Province, Southern China, reported an overall sample prevalence of 30.8% and a staggering farm-level prevalence of 76.7% across 30 farms [5]. These data indicate that while individual animal prevalence may vary, the virus is endemic at the herd level, with the vast majority of farms harboring the pathogen.

In Europe, PSV is similarly entrenched. A large-scale study in Corsica, France, detected PSV RNA in 62.0% of 908 fecal samples from 16 pig farms, demonstrating endemic circulation [27]. In Switzerland, a multiplex RT-PCR investigation of 363 samples from healthy and diseased pigs revealed PSV-A in 51% of fecal samples from healthy animals and 64% from diseased animals, with the highest frequencies observed in weaned and fattening pigs [28]. Italian studies have also confirmed high circulation, with one investigation finding that 63 of 64 fecal pools from young growers were positive for PSV across three farms [21]. Hungarian researchers identified a high prevalence of diverse PSV strains in both enteric and respiratory samples from 12 swine farms, including a potentially novel genotype [33]. Even in Northern Europe, such as the United Kingdom, historical isolates like the V13 strain from England have been used as reference points for global phylogenetic analyses [19]. The African continent, previously underrepresented in PSV research, has yielded critical data from Zambia. Harima et al. (2020) screened 147 fecal samples and found a prevalence of 36.2% in suckling pigs and a remarkable 94.0% in fattening pigs, underscoring the near-universal exposure of older animals in endemic settings [40]. In the Americas, PSV has been confirmed in the United States, with the first complete genome sequence (USA/IA33375/2015) obtained from a diarrheic pig, and its presence has been linked to a severe outbreak of polioencephalomyelitis in a finishing swine operation [25, 35]. Brazilian studies have extended the host range to captive wild boars (Sus scrofa scrofa), confirming that PSV circulates beyond domestic swine [26]. Finally, metagenomic analysis of diarrheic pigs in Australia has also identified PSV, confirming its truly global distribution [45].

Age-Related Prevalence and the Role of Maternal Immunity

One of the most consistent epidemiological features of PSV infection is its strong association with age. The virus exhibits a distinct age-related prevalence curve, with the highest detection rates typically observed in weaned and growing pigs, followed by a decline in older age classes. This pattern is driven by the waning of maternally derived antibodies (MDA) and the subsequent exposure to environmental viral loads. In a detailed epidemiological study from the Bareilly region of India, Kumari et al. (2018) reported that the highest prevalence was in the 29–56 days age group (33.3%), followed by the 57–140 days group (25%), with the lowest rates in 0–28-day-old piglets (13.9%) [54]. This pattern was corroborated by a Swiss study, which found that PSV was detected more frequently in fecal samples from weaned and fattening pigs compared to suckling piglets and sows [28]. The Zambian study by Harima et al. (2020) provided a stark illustration of this phenomenon, with prevalence jumping from 36.2% in suckling pigs to 94.0% in fattening pigs [40]. The low prevalence in very young piglets is attributable to the protective effect of colostral antibodies. As these antibodies wane, typically around weaning age (3–4 weeks), piglets become highly susceptible to infection from the contaminated environment. The high prevalence in growers and finishers reflects the cumulative exposure and the establishment of persistent or recurrent infections within the cohort. Interestingly, the prevalence in sows is often lower than in growing pigs, suggesting that prior exposure leads to a degree of protective immunity that reduces active shedding, although sows can still serve as a source of infection for their offspring [21, 28, 54].

Seasonal and Clinical Status-Associated Variations

Seasonal patterns in PSV prevalence have been documented, although the drivers are likely multifactorial, involving environmental stability of the virus, management practices, and host stress. A comprehensive study in Yunnan Province, China, found significant seasonal differences (p < 0.01), with the highest PSV positive rate observed in autumn (73.33%) and the lowest in summer (19.00%) [3]. This contrasts with findings from India, where the highest prevalence was recorded in winter (30%), followed by monsoon (23.3%) and summer (11.1%) [54]. These discrepancies may reflect regional climatic differences, such as temperature and humidity, which affect virus survival outside the host. PSV is a non-enveloped virus known for its environmental stability; it can survive in feed ingredients under simulated transboundary shipping conditions and is resistant to inactivation by heat and certain disinfectants [20, 43, 57]. Cooler, more humid conditions may prolong viral persistence in the environment, increasing the force of infection.

A critical and consistent finding across multiple studies is the significantly higher prevalence of PSV in diarrheic pigs compared to asymptomatic or healthy cohorts. This association is a cornerstone of the argument for PSV’s etiological role in enteric disease. In Yunnan Province, the PSV positive rate in diarrhea samples (47.26%) was significantly higher (p < 0.001) than in non-diarrhea samples (31.77%) [3]. Similarly, Li et al. (2019) reported that PSV-positive rates in pigs with diarrhea were much higher than in asymptomatic samples in China [13]. In a study from western Jiangxi, China, a high infection rate and viral load of PSV were found in nursery pigs, a demographic particularly prone to post-weaning diarrhea [14]. However, it is crucial to note that PSV is also frequently detected in healthy pigs. The Swiss study found PSV-A in 51% of fecal samples from healthy animals and 64% from diseased animals, and statistical analysis yielded no evidence for an association of virus detection and disease [28]. This dichotomy highlights the complex nature of PSV pathogenesis, where the virus can circulate subclinically in a population but may cause overt disease under specific conditions, such as high infectious dose, co-infection with other pathogens, or host immune compromise. The presence of PSV in healthy animals also underscores its role as an opportunistic or contributing pathogen rather than a strictly obligate cause of disease.

Co-infection Dynamics and the Enteric Virome

PSV rarely circulates in isolation. The swine enteric tract is a complex ecosystem, and PSV is frequently found as part of polymicrobial infections, particularly with other enteric viruses. The high prevalence of co-infections complicates the attribution of clinical signs to any single agent and suggests synergistic or antagonistic interactions that can influence disease outcome. A large-scale study in Shanghai, China, analyzing 3,256 fecal samples, identified PSV as one of the top three agents, with a positive rate of 20.71%, and found that mixed infection rates were high and complicated [32]. The predominant dual-infection models involving PSV included PEDV/PSV (9.29%), and the dominant quadruple-infection model was PEDV/PAstV/PSV/PKoV (46.82%) [32]. In the United States, a metagenomic analysis of 217 PEDV-positive diarrheic piglets revealed that 31% were also positive for Sapelovirus, and 73% of the piglets shed two to nine different viruses [38]. Specific co-infection rates have been quantified in several studies. In Yunnan Province, the co-infection rates of PSV with porcine rotavirus (PoRV) and PSV with porcine epidemic diarrhea virus (PEDV) were 5.07% and 3.04%, respectively [3]. A duplex qPCR study in China found a co-infection rate of PDCoV and PSV of 13.8% [7]. In Korea, the prevalence of PSV alone was 21.1% in animals with diarrhea and respiratory signs, while the prevalence of PSV mixed with other pathogens was also 21.1% [31].

The clinical significance of these co-infections is an area of active investigation. The logistic regression model developed by Li et al. (2025) confirmed that PAstV, PKoV, BVDV, and PEDV were closely related to porcine diarrhea, and that specific co-infection models (e.g., PEDV/PKoV, PKoV/BVDV) had great co-infection dominance [32]. This suggests that PSV may act as a "fellow traveler" or a potentiating factor, where its presence, combined with other pathogens, overwhelms host defenses and leads to more severe clinical outcomes than any single agent alone. The biological plausibility of this is supported by the observation that PSV, like other picornaviruses, can modulate the host immune response. For instance, the PSV 3C protease inhibits the production of type I interferon by cleaving mitochondrial antiviral signaling (MAVS) and degrading MDA5 and TBK1 [9]. This immunosuppressive effect could create a permissive environment for co-infecting pathogens, exacerbating disease. Furthermore, the virus induces mitochondrial-dependent apoptosis via its 2A protein, which could compromise intestinal barrier integrity and facilitate secondary infections [12].

Prevalence in Wild Boar and Potential for Interspecies Transmission

The epidemiology of PSV extends beyond domestic swine to include wild boar populations, which can act as reservoirs and potential sources of reintroduction into commercial herds. A study in Paraná state, Brazil, detected PSV in fecal samples from asymptomatic captive wild boars (Sus scrofa scrofa), confirming natural infection in this species [26]. In Korea, serological surveillance of wild boars over a five-year period (2019–2024) showed a slight decrease in PSV antibody prevalence (by 1.8%), but the virus remains endemic in the wild population [31]. The role of wild boar in the long-distance dissemination of PSV is likely significant, given their wide-ranging movements and the environmental stability of the virus. Moreover, the potential for interspecies transmission to other animals has been raised. Studies in Ukraine have isolated viruses from synanthropic animals (cats, chickens, wild geese) that were shown to be pathogenic for pigs, suggesting that these animals could serve as mechanical vectors or even biological hosts [39]. However, experimental studies have shown that a Korean PSV strain could not replicate in chicks, indicating that porcine-specific factors are required for productive infection [56]. The detection of PSV in a human hepatocarcinoma cell line (PLC/PRF/5) and its ability to cause rapid cytopathic effects highlights its broad in vitro tropism, but there is currently no evidence of zoonotic transmission [20, 58]. The World Organisation for Animal Health (WOAH) does not list PSV as a notifiable pathogen, but its high prevalence and potential for economic impact through reduced performance and increased mortality warrant continued surveillance.

Methodological Considerations and Diagnostic Impact on Prevalence Estimates

The reported prevalence of PSV is highly sensitive to the diagnostic method employed. Traditional virus isolation in cell culture, while valuable for obtaining isolates for characterization, is less sensitive than molecular methods. Studies have shown that cultured PSV strains do not always represent the dominant PSVs found in vivo, introducing a selection bias [33]. Conventional RT-PCR has been widely used, but real-time quantitative PCR (RT-qPCR) assays, including SYBR Green I-based and TaqMan probe-based methods, offer superior sensitivity and specificity [1, 7, 14, 23, 49]. For example, a TaqMan-based real-time PCR assay developed by Kumari et al. (2018) detected PSV in 23.3% of samples compared to 17.7% by conventional RT-PCR, demonstrating a significant increase in diagnostic sensitivity [23]. Similarly, a SYBR Green I-based RT-PCR method was found to be more sensitive than conventional PCR [14]. The development of multiplex assays, such as the quadruplex RT-qPCR for PSV, PKV, PTV, and EV-G, allows for high-throughput screening and a more accurate assessment of the co-infection landscape [1]. The use of next-generation sequencing (NGS) and metagenomics has further revolutionized our understanding, revealing the presence of PSV in complex viromes and identifying novel or divergent strains that might be missed by targeted PCR [10, 27, 38, 41, 44, 45]. Serological assays, such as the indirect ELISA based on the VP1 protein or the nonstructural protein 3AB, provide a measure of past exposure and can distinguish infected from vaccinated animals (DIVA), but they do not measure active infection [4, 8, 11]. The first indirect ELISA for PSV antibody detection, developed by Ibrahim et al. (2022), reported a seroprevalence of 79.3% in 516 swine serum samples, a figure that aligns with the high exposure rates inferred from molecular studies [8]. The choice of diagnostic tool must therefore be carefully considered when interpreting prevalence data, with molecular assays providing a snapshot of active shedding and serological assays indicating cumulative lifetime exposure.

Clinical Manifestations and Associated Diseases of Porcine Sapelovirus

Porcine sapelovirus (PSV) is a member of the genus Sapelovirus within the family Picornaviridae and is recognized as an emerging pathogen with a remarkably broad clinical spectrum [17, 36]. The virus is capable of inducing a wide array of pathological conditions, ranging from subclinical infections to severe, multi-systemic disease. The clinical manifestations of PSV infection are not solely a function of viral virulence but are profoundly influenced by host age, immune status, co-infection with other pathogens, and environmental stressors [28, 54]. The virus is primarily enteropathogenic, yet its capacity for extra-intestinal dissemination, including neurotropism, has been experimentally and clinically documented [55, 56]. This section provides an exhaustive analysis of the clinical syndromes associated with PSV, drawing on a substantial body of experimental and epidemiological evidence.

Enteric Disease: Diarrhea and Intestinal Pathology

The most frequently reported clinical manifestation of PSV infection is acute enteritis, characterized predominantly by diarrhea [2, 3, 13]. This syndrome is of paramount economic importance, particularly in neonatal and weanling piglets, where it contributes to significant morbidity, mortality, and growth retardation [6, 15]. The association between PSV and diarrhea has been confirmed through numerous cross-sectional studies. For instance, in a large-scale epidemiological survey in Yunnan Province, China, the PSV positive rate in diarrheic samples (47.26%) was significantly higher than that in non-diarrheic samples (31.77%), strongly implicating PSV in the etiology of porcine diarrhea [3]. Similarly, studies from Fujian Province and elsewhere have consistently identified PSV as a primary agent in diarrheic piglets, with prevalence rates often exceeding 30% in affected herds [5, 7, 14].

The severity of PSV-associated diarrhea can vary from mild, transient episodes to profuse, watery diarrhea leading to dehydration and death in severe cases [10, 24]. Experimental infection models have been instrumental in confirming the causal role of PSV in enteric disease. Oral inoculation of neonatal piglets with various PSV strains, including PSV-HNHB-01, PSV-JXXY-a2, and the Korean SV-A strain, consistently induces clinical diarrhea, often accompanied by inappetence and lethargy [6, 13, 56]. Notably, the GS01 strain isolated in western China was reported to induce "serious diarrhea" in neonatal piglets, causing an inflammatory response and significant intestinal damage [10]. The pathological basis of this diarrhea is a severe, catarrhal to hemorrhagic enteritis. Gross pathological lesions typically include thickening of the intestinal mucosa, congestion of the intestinal blood vessels, and frothy exudates in the intestinal lumen [18, 51]. Microscopic examination reveals profound villous atrophy, sloughing of villous epithelium, and infiltration of the lamina propria with mononuclear cells, predominantly plasma cells, indicative of a robust inflammatory response [18, 53]. Immunohistochemical (IHC) studies have localized PSV antigen specifically to the epithelial cells of the large and small intestines, confirming a direct viral cytopathic effect on enterocytes [53, 56]. The virus's ability to induce apoptosis in infected cells, mediated in part by the 2A protein, may contribute to the observed epithelial cell loss and subsequent intestinal barrier dysfunction [12].

Neurological Disease: Polioencephalomyelitis

Beyond its enteric tropism, PSV is a well-documented cause of severe neurological disease, specifically polioencephalomyelitis, a condition characterized by inflammation of the gray matter of the brain and spinal cord [10, 35]. This manifestation, while less frequent than diarrhea, carries a high case-fatality rate and is a critical concern for swine health. The association between PSV and neurological signs was dramatically highlighted in a seminal outbreak in a finishing swine operation in the United States, where PSV was identified as the causative agent of an atypical neurological disease in 11-week-old pigs [35]. The outbreak was characterized by a 20% morbidity and a 30% case fatality rate. Affected pigs exhibited a progressive clinical course including inappetence, compromised ambulation, ataxia, incoordination, mental dullness, paresis, paralysis, and a decreased response to environmental stimuli. Histopathological examination confirmed severe lymphoplasmacytic and necrotizing polioencephalomyelitis, and Sapelovirus A mRNA was detected in neurons and nerve roots via in situ hybridization, providing definitive evidence of neuroinvasion [35].

This neurotropic potential has been corroborated by experimental studies. Inoculation of Korean SV-A strains into piglets induced mild, non-suppurative myelitis and encephalitis, demonstrating the virus's capacity to invade the central nervous system (CNS) even when clinical neurological signs are not overt [56]. Furthermore, studies in India have reported perivascular cuffing, neuronophagia, and focal gliosis in the brains of naturally infected pigs, confirming that PSV can induce significant CNS pathology under field conditions [18, 51]. The virus appears to spread to the CNS following primary replication in the gut, likely via the bloodstream or neural routes [55]. It is important to note that not all PSV strains are equally neurovirulent. For example, the PSV/Goryeong/KR-2019 strain from Korea was shown to be weakly pathogenic, failing to induce neurological signs in 130-day-old pigs and showing no specific histopathological lesions in brain tissue [31]. This underscores the genetic and phenotypic diversity within PSV populations and suggests that specific viral genetic determinants, perhaps within the capsid or non-structural proteins, govern neurotropism.

Respiratory and Reproductive Manifestations

PSV infection is also associated with respiratory distress and reproductive failure, though these syndromes are less comprehensively documented than enteric and neurological disease. Respiratory signs, including pneumonia and dyspnea, have been reported in both natural and experimental settings [15, 18]. Interstitial pneumonia is a frequent microscopic finding in PSV-positive pigs, with severe to moderate congestion of the lungs and frothy exudates in the trachea observed grossly [18, 51]. Experimental inoculation of piglets with the SHCM2019 strain resulted in both diarrhea and pneumonia, confirming a primary respiratory pathogenic potential [15].

Reproductive disorders, often grouped under the acronym SMEDI (Stillbirth, Mummification, Embryonic Death, and Infertility), are a classical, though inconsistently observed, component of PSV-associated disease [5, 17, 36]. The virus has been detected in aborted fetuses, stillborn piglets, and cases of reproductive failure, although the precise role of PSV in these events can be difficult to disentangle from co-infections [6, 16, 28]. A study on placental and abortion samples from Swiss pigs, however, did not detect PSV, suggesting that its role in reproductive disease may be sporadic or dependent on specific viral strains or herd conditions [28]. Nevertheless, the detection of PSV in reproductive tissues and its association with fertility disorders in field surveys solidifies its status as an agent capable of causing reproductive dysfunction [4, 31].

The Role of Co-Infections in Clinical Disease Severity

A defining characteristic of PSV in the field is its pronounced tendency to co-infect with other enteric and respiratory pathogens. This phenomenon is a major driver of disease severity and complexity. The clinical picture of PSV infection is rarely a monoinfection; instead, it is often part of a polymicrobial challenge. Metagenomic studies have consistently revealed a high prevalence of PSV alongside other viruses in diarrheic pigs. A study on PEDV-positive piglets in the US found that 31% of samples were also co-infected with PSV, and 73% of piglets shed between 2 and 9 different viruses simultaneously [38]. In Chinese pig herds, the most common co-infection patterns involving PSV include dual infections with porcine kobuvirus (PKoV) and porcine astrovirus (PAstV), and triple infections with PEDV, PSV, and PAstV [32]. Co-infection with porcine deltacoronavirus (PDCoV) is also highly prevalent, with one study reporting a 13.8% co-infection rate [7].

The clinical implications of these co-infections are profound. The synergistic or additive effects of multiple pathogens can overwhelm the host's immune system, leading to more severe diarrhea, greater dehydration, higher mortality, and prolonged recovery. For instance, PSV is frequently detected in cases of porcine respiratory disease complex (PRDC) and is often isolated alongside other respiratory viruses like porcine reproductive and respiratory syndrome virus (PRRSV) [4]. Similarly, PSV co-infections with Lawsonia intracellularis, Brachyspira spp., and other bacteria have been linked to poor growth and diarrhea in growing pigs, indicating a role in multifactorial enteric disease [45]. The clinical management of PSV, therefore, cannot be divorced from the broader polymicrobial context of the farm. The development of sensitive multiplex detection assays, such as the quadruplex RT-qPCR, is therefore crucial for accurate diagnosis and for guiding appropriate intervention strategies [1, 59].

Subclinical Infections and Carrier States

A substantial proportion of PSV infections are subclinical, with the virus circulating silently within a herd. This is particularly true in adult animals and in herds with good immunity and management. Studies from Switzerland, for instance, detected PSV in 51% of fecal samples from healthy weaned and fattening pigs, with no statistically significant association between virus detection and clinical disease [28]. Similarly, high viral detection rates (up to 62%) were found in asymptomatic pigs in Corsica, France [27]. This high prevalence of subclinical infection suggests that PSV is a ubiquitous component of the porcine enteric virome and that clinical disease likely results from a combination of host susceptibility, viral strain virulence, and environmental triggers [21, 28].

The carrier state is a critical epidemiological feature. PSV is shed in the feces for prolonged periods, even in the absence of clinical signs, facilitating continuous environmental contamination and transmission within and between farms [36]. The virus is remarkably stable in the environment and can survive in feed ingredients and under transboundary shipping conditions, posing a risk for long-distance spread [43]. This asymptomatic shedding is the primary mechanism by which the virus persists in populations, making eradication challenging. The existence and role of persistently infected carrier pigs are a key area for future research, as they represent a constant source of viral re-introduction into naïve populations and a complicating factor for control programs.

Pathogenetic Mechanisms Underlying Clinical Disease

The clinical manifestations of PSV are a direct consequence of its molecular interactions with the host. The virus enters cells via caveolae-dependent endocytosis, utilizing α2,3-linked sialic acid on the GD1a ganglioside as a functional receptor [47, 48, 50]. This receptor is abundant in porcine intestinal epithelial cells, explaining the virus's primary enterotropism. Once inside the host cell, PSV manipulates cellular machinery to its advantage. A key mechanism in the pathogenesis of enteric disease is the induction of apoptosis via the mitochondrial pathway, a process mediated by the viral 2A protein [12]. The 2A protein's protease activity is essential for triggering this programmed cell death, leading to the loss of enterocytes, villous atrophy, and the manifestation of diarrhea.

On the host side, the virus employs sophisticated immune evasion strategies. The 3C protease (3Cpro) of PSV is a potent antagonist of the type I interferon (IFN) response, a critical arm of the innate antiviral defense. PSV 3Cpro cleaves the mitochondrial antiviral signaling protein (MAVS) and degrades melanoma differentiation-associated gene 5 (MDA5) and TANK-binding kinase 1 (TBK1), thereby effectively blocking the induction of IFN-β [9]. This suppression of the interferon response allows the virus to replicate to high titers and spread before adaptive immunity is fully mobilized, contributing to the severity of disease. The interplay between these pro-apoptotic and immune-evasion mechanisms shapes the overall clinical outcome.

Age-Dependent Susceptibility and Clinical Expression

The age of the pig is a primary determinant of the severity and nature of PSV-associated disease. Young piglets, particularly suckling and nursery pigs, are the most susceptible to severe clinical disease. Epidemiological data consistently show higher prevalence and viral loads in younger age groups. In one study, PSV prevalence was highest in 29-56-day-old piglets (33.3%) compared to older groups [54]. Similarly, studies from Zambia and Switzerland found the highest infection rates in suckling and fattening pigs [28, 40]. This age-related susceptibility likely stems from the waning of maternally derived antibodies coupled with an immature adaptive immune system, making neonates more vulnerable to infection and disease progression.

In contrast, clinical disease in sows and older pigs is less common, and infections are often subclinical or manifested as mild, transient diarrhea or reproductive failure [21, 28]. This pattern suggests that previous exposure leads to the development of protective immunity that can limit viral replication and systemic spread. However, even in older animals, the virus can persist and be shed, maintaining its circulation within the herd. The age-related differences in clinical expression highlight the importance of targeted management strategies, with the highest level of biosecurity and monitoring required for the most susceptible age groups.

A Spectrum of Virulence: From Weakly to Highly Pathogenic Strains

A critical insight from recent research is the substantial variation in virulence among different PSV strains. While some isolates, like the GS01 strain from western China, can cause severe, life-threatening diarrhea in neonatal piglets, others appear to be weakly pathogenic [10, 31]. The Korean PSV/Goryeong/KR-2019 strain, for example, caused only mild diarrhea in suckling pigs and no neurological signs in fattening pigs, despite being isolated from a clinical case [31]. This variability is driven by genetic diversity, particularly in the capsid genes (VP1, VP2, VP3) and the non-structural proteins. Studies have identified recombination events and point mutations in these regions that may alter receptor binding affinity, tissue tropism, or the ability to evade the host immune response [2, 5, 6]. The presence of a 12-nucleotide insertion in the VP1 gene of the PSV2020 strain, resulting in a four-amino-acid insertion (STAE), is a striking example of this genetic plasticity [5]. The clinical significance of these genetic variations is an active area of investigation, but it is clear that not all PSV strains pose an equal threat, and that continued molecular surveillance is essential for detecting the emergence of highly pathogenic variants.

Laboratory Diagnostics and Detection Methods for Porcine Sapelovirus

The accurate and timely detection of Porcine Sapelovirus (PSV) is a cornerstone of effective disease surveillance, outbreak management, and fundamental research into the pathogenesis and epidemiology of this increasingly recognized swine pathogen. Given the ability of PSV to manifest as a subclinical infection or to precipitate a spectrum of severe clinical outcomes, including acute diarrhea, polioencephalomyelitis, reproductive failure, and respiratory distress [3, 5, 8], the diagnostic armamentarium must be both exquisitely sensitive and highly specific. Furthermore, the frequent occurrence of PSV in complex co-infections with other enteric and extraintestinal pathogens, such as Porcine Epidemic Diarrhea Virus (PEDV), Porcine Kobuvirus (PKV), Porcine Teschovirus (PTV), and Enterovirus G (EV-G), necessitates the deployment of multiplexed and differential diagnostic platforms [1, 32, 38]. The diagnostic landscape for PSV has evolved substantially from traditional virus isolation techniques to advanced molecular assays and serological tools, each with distinct applications and interpretative caveats that are critical for the veterinary diagnostician and researcher to comprehend.

Molecular Detection Methodologies: The Vanguard of PSV Diagnostics

The advent and widespread adoption of nucleic acid amplification technologies (NAATs) have revolutionized the detection of PSV, offering unparalleled sensitivity, specificity, and speed compared to classical virological methods. These assays primarily target highly conserved genomic regions, notably the 5' untranslated region (5'UTR) and the RNA-dependent RNA polymerase (3D) gene, to ensure broad detection of diverse circulating strains [18, 23, 51].

Real-Time Quantitative RT-PCR (RT-qPCR) and Multiplex Strategies

Real-time quantitative RT-PCR (RT-qPCR) has become the gold standard for PSV detection, providing both qualitative presence/absence data and quantitative viral load information. The development of a quadruplex RT-qPCR assay exemplifies the cutting edge of this technology, enabling the simultaneous detection and differentiation of PSV, PKV, PTV, and EV-G in a single reaction. This novel assay demonstrated remarkable analytical performance, with a sensitivity and specificity that yielded coincidence rates exceeding 99.01% when compared to reference uniplex assays. Its application to 1,823 clinical fecal samples revealed a PSV positivity rate of 15.25% (278/1823) and underscored the clinical reality of extensive co-circulation of these picornaviruses within swine herds [1]. Similarly, a duplex real-time qPCR based on SYBR Green I was engineered for the concurrent detection of PSV and Porcine Deltacoronavirus (PDCoV), achieving detection limits of 1.0 × 10² copies/μL for PSV. This assay's specificity was confirmed by the absence of cross-reactivity with other porcine diarrhea-associated viruses, and it identified a PSV positive rate of 23.2% in clinical samples, with a co-infection rate of 13.8% for PDCoV and PSV [7]. A separate TaqMan-based real-time PCR assay, targeting the highly conserved 5'UTR, pushed the detection limit to 10² copies, demonstrating superior sensitivity over conventional RT-PCR. In a comparative evaluation of 90 fecal samples, the TaqMan assay identified 23.3% as positive, compared to only 17.7% by conventional RT-PCR, a difference of nearly six percentage points that highlights the risk of false negatives with less sensitive methods [23, 54].

Beyond these multiplex approaches, a one-step triplex reverse-transcription PCR assay was designed to simultaneously detect PEDV, PSV, and Porcine Sapovirus (SaV). This method, which exhibited 97.6% concordance for PSV detection when validated against 402 clinical samples, offers a cost-effective and rapid alternative for laboratories needing to screen for these three common enteric pathogens [59]. The choice between these platforms often hinges on the specific diagnostic question; TaqMan probes provide enhanced specificity through fluorogenic probes, while SYBR Green assays offer a more economical option for initial screening. The selection of appropriate primer and probe sets is paramount, as genetic diversity in PSV, particularly in the VP1 gene, can lead to amplification failures if targets are not carefully chosen from conserved genomic stretches [3, 5, 16].

Conventional RT-PCR, Genotyping, and Isothermal Amplification

While real-time methods are increasingly preferred, conventional RT-PCR remains a robust and accessible tool, particularly for genotyping and sequencing efforts. Amplification of the complete VP1 gene, a region critical for serotype determination and evolutionary analyses, is routinely performed to characterize PSV strains. A SYBR Green I-based conventional RT-PCR method was developed specifically for PSV, demonstrating high specificity and sensitivity, and was instrumental in revealing an overall PSV positivity rate of 11.22% in fecal samples from Jiangxi, China [14]. The utility of VP1-targeted RT-PCR extends to phylogenetic classification, allowing the differentiation of PSV into distinct genotypes (PSV-1 and PSV-2) based on sequence divergence, with established cut-off values of 0.272 for VP1 amino acid distances [16, 33]. This molecular typing is essential for tracking the global and regional spread of viral lineages and for identifying emerging recombinants, which are frequently detected in PSV populations [2, 5, 6].

For field-deployable diagnostics or resource-limited settings, isothermal amplification methods offer a compelling alternative to thermocycler-dependent assays. A reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for PSV was developed, capable of detecting as few as 10 copies/μL of viral RNA. The reaction is performed at a constant temperature of 63°C, typically in a water bath or heat block, and results can be visualized by the naked eye. This RT-LAMP assay demonstrated superior sensitivity compared to both SYBR Green-based RT-PCR and conventional RT-PCR, making it a powerful tool for rapid, on-site diagnosis [49].

Virus Isolation and Characterization: The Foundational Approach

Despite the supremacy of molecular methods for primary detection, virus isolation in cell culture remains an indispensable technique for obtaining infectious virus for downstream applications, including vaccine development, pathogenesis studies, and detailed antigenic characterization. The successful isolation of PSV is highly dependent on the choice of cell line. Porcine kidney cell lines, such as PK-15 and SK6, are the most widely used and have proven effective for isolating PSV from clinical samples, including fecal specimens and intestinal contents [2, 8, 13]. Continuous swine testis (ST) cells are also highly permissive, as demonstrated during the serial passage of the PSV HNHB-01 strain, where the virus was successfully adapted over 100 passages [6]. Interestingly, the human hepatocarcinoma cell line PLC/PRF/5 is also exquisitely susceptible to PSV, often producing rapid and extensive cytopathic effect (CPE). This property, while useful for PSV isolation, creates a significant challenge when attempting to isolate other viruses, such as Hepatitis E Virus, from PSV-co-infected samples. This challenge was specifically overcome through the development of a PSV infection-resistant cell line, N1380, derived from PLC/PRF/5 cells, enabling the successful isolation of HEV and Mammalian Orthoreoviruses from otherwise contaminated specimens [58, 60]. Other cell lines of porcine origin, such as IB-RS-2 and porcine embryonic kidney cells, have also been used successfully for primary isolation [19, 34].

For characterization, the isolated virus is typically identified and confirmed through a combination of techniques. First, CPE, characterized by cell rounding, detachment, and eventual monolayer destruction, is observed, typically within 2-5 days post-inoculation. This CPE is then confirmed as PSV-specific via immunofluorescence assay (IFA) using polyclonal or monoclonal antibodies directed against the VP1 protein [6, 8, 15, 24]. The physical properties of the virion are then assessed using transmission electron microscopy (TEM), which reveals non-enveloped, icosahedral particles with a diameter of approximately 25-35 nm [2, 8, 20, 24]. A detailed analysis of the buoyant density of PSV particles via isopycnic centrifugation in cesium chloride gradients has revealed two distinct populations of particles: a dense, infectious fraction (approximately 1.300 g/cm³) and a lighter, possibly empty or defective fraction (approximately 1.285 g/cm³) [20]. The initial steps of viral entry into host cells are also a focus of characterization; PSV has been shown to utilize α2,3-linked sialic acid on the GD1a ganglioside as a functional receptor [47] and to enter permissive cells such as PK-15 and IPEC-J2 through a caveolae/lipid raft-dependent, pH-dependent, and dynamin-dependent endocytic pathway [48, 50].

Serological and Immunological Assays: Uncovering the Immune Landscape

While NAATs detect viral nucleic acid, serological assays are essential for determining prior exposure, monitoring herd immunity, and evaluating vaccine efficacy. The development of robust serological tools for PSV has been comparatively slower than for molecular diagnostics, but significant progress has been made in recent years. The most widely reported approach is the indirect enzyme-linked immunosorbent assay (ELISA). A landmark study reported the first indirect ELISA for detecting PSV antibodies, utilizing recombinant PSV-VP1 protein as the coating antigen. This assay demonstrated its field utility by testing 516 swine serum samples, revealing a remarkably high PSV seropositive rate of 79.3%, underscoring the extensive circulation of the virus even in clinically normal herds [8].

A critical advancement in PSV serology is the development of a DIVA (Differentiating Infected from Vaccinated Animals) ELISA. This assay is based on the detection of antibodies against the nonstructural protein 3AB. Because inactivated or subunit vaccines are typically devoid of nonstructural proteins, antibodies to 3AB are induced only in animals that have experienced natural infection and active viral replication. This indirect ELISA, using recombinantly expressed PSV 3AB protein, exhibited exceptional diagnostic performance with a sensitivity of 99.78% and a specificity of 100.0%. Importantly, it showed no cross-reaction with antibodies against other major swine viruses, including PRRSV, CSFV, PRV, PEDV, and FMDV, making it a highly reliable tool for DIVA-based control programs [4].

Monoclonal antibodies (mAbs) directed against the viral capsid have been developed to enhance the specificity of serological detection. Two novel mAbs against the PSV VP1 protein were generated, and their epitopes were precisely mapped. One mAb, 15E4, recognizes a highly conserved linear B-cell epitope, ²⁰³YDGDG²⁰⁷, which is present across different PSV genotypes. This conservation suggests that this specific epitope could be an excellent target for a universal serological detection method. In contrast, the epitope for a second mAb, 9F10 (⁸QAIVNRT¹⁴), was found to be highly variable among PSV strains, making it less suitable for broad-spectrum diagnostics but potentially useful for strain-specific differentiation [11]. Furthermore, immunohistochemistry (IHC) on formalin-fixed, paraffin-embedded tissues provides a valuable tool for visualizing the spatial distribution of viral antigen within affected tissues. Using hyperimmune rat serum raised against PSV, IHC was successfully applied to detect viral antigens in the intestinal epithelial cells of naturally infected pigs, conclusively linking the presence of virus to histopathological lesions of severe enteritis in the large and small intestines [53]. These techniques collectively provide both a snapshot of current infection and a historical record of exposure, offering a complete picture of PSV dynamics within a population.

Prevention and Control Strategies for Porcine Sapelovirus Infections

The prevention and control of Porcine Sapelovirus (PSV) infections present a formidable challenge to the global swine industry, primarily due to the virus’s ubiquitous nature, high environmental stability, genetic plasticity, and frequent subclinical presentation. Unlike pathogens that elicit robust, sterilizing immunity or those for which highly effective commercial vaccines exist, PSV control must be approached through an integrated, multi-layered strategy. This strategy must encompass robust biosecurity, enhanced surveillance and rapid differential diagnostics, the development of DIVA-compatible vaccines, targeted antiviral interventions based on viral pathogenesis, and a deep understanding of the epidemiological drivers of transmission. The absence of a licensed, widely available vaccine [36] places an even greater emphasis on non-immunological control measures and the rigorous application of management practices designed to break the fecal-oral transmission cycle.

Biosecurity, Hygiene, and Environmental Stability Mitigation

The cornerstone of PSV control, in the absence of widespread vaccination, is the implementation of stringent biosecurity protocols coupled with rigorous sanitation. PSV is a non-enveloped picornavirus, a characteristic that confers exceptional resistance to environmental inactivation and many common disinfectants. The virus has been shown to survive in a wide range of environmental conditions and feed ingredients, posing a risk for transboundary and domestic transmission. For instance, PSV was used as a surrogate for Swine Vesicular Disease Virus (SVDV) in transboundary shipping models and maintained infectivity during simulated transport in conventional soybean meal, lysine hydrochloride, choline chloride, vitamin D, and pork sausage casings [43]. This finding underscores the potential for contaminated feed and feed ingredients to serve as vehicles for PSV introduction into naive herds.

Specific inactivation parameters have been defined. PSV is rapidly inactivated by heating at 60°C for 10 minutes or 65°C for 5 minutes [20]. In the context of feed safety, the production of spray-dried porcine plasma (SDPP), a common feed ingredient, requires specific thermal and physical conditions to inactivate PSV alongside other pathogens like PEDV and PCV2 [57]. Chemical inactivation is achievable but requires careful selection. The virus loses infectivity when exposed to 62.5 ppm of sodium hypochlorite (NaClO) for 30 minutes [20]. However, its resistance to many standard disinfectants necessitates the use of validated virucidal agents, particularly oxidizing agents and high-level disinfectants, for cleaning contaminated facilities, transport vehicles, and equipment.

Management practices must focus on breaking the fecal-oral cycle, the primary route of transmission. This includes strict all-in/all-out production flows, thorough cleaning and disinfection between groups, dedicated footwear and clothing for barn personnel, and rigorous rodent and insect control. The high prevalence of PSV in wild boar populations further complicates control, as these animals can serve as a reservoir and source of introduction into domestic herds [26, 31]. Biosecurity measures must therefore include preventing contact between domestic pigs and feral swine, as well as ensuring that water sources are not contaminated by wildlife.

Enhanced Surveillance and Differential Diagnostics

Effective control is predicated on accurate and timely diagnosis. The clinical signs of PSV, diarrhea, respiratory distress, polioencephalomyelitis, and reproductive failure, are indistinguishable from those caused by a plethora of other swine pathogens, including Porcine Epidemic Diarrhea Virus (PEDV), Porcine Deltacoronavirus (PDCoV), Porcine Rotavirus (PoRV), Porcine Teschovirus (PTV), and Porcine Enterovirus G (EV-G) [1, 7, 32, 59]. Therefore, reliance on clinical observation alone is insufficient. Molecular diagnostics, particularly real-time quantitative PCR (RT-qPCR), are essential for accurate detection and differentiation.

Recent advances have led to the development of highly efficient multiplex assays capable of simultaneously detecting and differentiating PSV from other major enteric and neurological pathogens. A quadruplex RT-qPCR for the simultaneous detection of PSV, PKV, PTV, and EV-G demonstrated high sensitivity, strong specificity, and excellent repeatability, with detection rates of 15.25% in fecal samples and coincidence rates exceeding 99% compared to single-target assays [1]. Similarly, a duplex SYBR Green I-based qPCR for PDCoV and PSV was developed, offering a low-cost alternative for simultaneous detection of these two diarrheal agents [7]. For broader surveillance, a one-step triplex RT-PCR for PEDV, PSV, and Porcine Sapovirus (SaV) has been validated [59]. Even more rapid, field-deployable methods like reverse transcription loop-mediated isothermal amplification (RT-LAMP) have been developed, offering a detection limit of 10 copies/μL at a constant temperature of 63°C, bypassing the need for expensive thermocyclers [49]. The application of high-throughput sequencing (HTS) and viral metagenomics in diagnostic and surveillance programs is also critical. HTS has revealed a complex co-infection landscape, with PSV frequently detected alongside up to 8 other viral genera in pigs with diarrhea, including PEDV, Mamastrovirus, Enterovirus, and Kobuvirus [38, 41, 44, 45]. This polymicrobial nature of disease complicates control efforts and underscores the need for comprehensive diagnostic panels.

Beyond detecting the virus itself, serological surveillance provides crucial data on the immune status of a herd and the extent of viral circulation. The development of an indirect ELISA using the recombinant VP1 protein has allowed for large-scale serological surveys, revealing a high PSV seroprevalence of 79.3% in tested swine serum samples [8]. More importantly, the development of a DIVA (Differentiating Infected from Vaccinated Animals) ELISA utilizing the non-structural protein 3AB is a significant breakthrough [4]. This assay, which shows 99.78% sensitivity and 100% specificity, can differentiate animals that have been naturally infected (which will have antibodies to both structural and non-structural proteins) from those that have received a killed or subunit vaccine (which would only have antibodies to structural proteins like VP1). This tool is indispensable for monitoring the effectiveness of any future vaccination campaign and for certifying herds as free from active infection.

Vaccine Development and Immunological Considerations

To date, there is no commercially available vaccine for PSV [36]. However, the urgent need for one is driven by the virus's economic impact and its role in multifactorial disease complexes. The path to an effective vaccine is fraught with challenges, primarily stemming from the virus's high genetic diversity, frequent recombination, and the specific immune evasion strategies it employs.

The VP1 capsid protein, which contains critical neutralizing epitopes and is the primary target for vaccine design, exhibits substantial genetic heterogeneity. Phylogenetic analyses have classified PSV into at least two genotypes, PSV-1 and PSV-2, with a potentially novel third genotype identified in Hungary [16, 33]. Within genotypes, the VP1 gene is hypervariable, and positive selection pressure has been detected at specific codons (e.g., the 95th amino acid), which may allow the virus to escape host immune responses [3]. Furthermore, insertions of additional amino acids in the VP1 protein, such as the four-amino-acid insertion (STAE) observed in a Fujian isolate, can alter antigenic topology and potentially compromise vaccine efficacy [5]. The presence of multiple genetic lineages circulating simultaneously within the same farm, as seen in Italy, further complicates vaccine design, suggesting that a monovalent vaccine may not provide adequate protection [21].

Another critical hurdle is the virus's capacity to antagonize the host innate immune response. PSV's 3C protease (3Cpro) is a potent virulence factor that directly suppresses the production of type I interferon (IFN-β), a key antiviral cytokine [9]. PSV 3Cpro achieves this by cleaving the mitochondrial antiviral signaling protein (MAVS) and degrading melanoma differentiation-associated gene 5 (MDA5) and TANK-binding kinase 1 (TBK1) [9]. By shutting down this critical signaling pathway, PSV creates an environment permissive for its own replication and delays the adaptive immune response. An effective vaccine would need to elicit a robust, high-titer antibody response that can neutralize the virus before it can establish infection and deploy these immune evasion mechanisms.

Despite these obstacles, progress is being made. Several research groups have successfully isolated and characterized pathogenic PSV strains, providing the necessary seed viruses for potential inactivated or live-attenuated vaccine candidates [2, 6, 10, 13, 15]. Pathogenicity studies in neonatal piglets have demonstrated that certain strains, like PSV-JXXY-a2 and the PSV GS01 strain, can consistently cause severe diarrhea and systemic infection, making them relevant challenge models for vaccine efficacy trials [10, 13]. The complete genome sequencing of these isolates has also provided insights into the genetic determinants of virulence and attenuation [6, 29]. The successful expression of the immunogenic VP1 protein [8, 11] and the identification of conserved B-cell epitopes, such as the 203YDGDG207 motif, offer promising targets for subunit or epitope-based vaccines that might provide broader protection across different PSV genotypes [11].

Antiviral and Host-Targeted Strategies

A complementary approach to vaccination involves the development of direct-acting antivirals or host-directed therapies that block viral replication. Detailed knowledge of the PSV life cycle, including viral entry, replication, and egress, has revealed several potential therapeutic targets.

PSV entry into host cells is a multistep process that has been well-characterized. The virus first binds to its primary receptor, α2,3-linked sialic acid on the GD1a ganglioside [47, 56]. This initial interaction could be targeted by compounds that competitively inhibit binding (e.g., sialic acid analogs) or by agents that deplete cell surface GD1a. Following attachment, PSV is internalized via caveolae-dependent endocytosis, a process that requires dynamin, low pH, and the GTPases Rab7 and Rab11 [48, 50]. Inhibitors of this pathway, such as dynasore (a dynamin inhibitor), nystatin, and methyl-β-cyclodextrin (MβCD) (which disrupt lipid rafts and caveolae), have been shown to dramatically reduce PSV infection in vitro [48, 50]. While these compounds are not directly suitable as therapeutics for use in food animals, they provide a proof-of-concept and serve as chemical probes for discovering more suitable pharmacological agents that can modulate these host pathways.

Viral-induced apoptosis is another critical aspect of PSV pathogenesis. The 2A protein of PSV is a key inducer of mitochondrial-dependent apoptosis, and its protease activity is essential for this function [12]. Specifically, conserved residues H48, D91, and C164 within the 2A protein are crucial for inducing the intrinsic apoptotic pathway [12]. Small molecule inhibitors that target the 2A protease could theoretically inhibit PSV replication and reduce virus-induced tissue damage. Furthermore, the host protein syndecan-1 (SDC1) has been identified as a novel host factor that promotes PSV replication; overexpression of SDC1 enhances VP1 synthesis and viral titers, while silencing it reduces replication [52]. This suggests that SDC1 or its downstream signaling partners could be potential targets for host-directed antiviral therapy.

Epidemiological Insights Guiding Intervention Strategies

Targeted control efforts are most effective when guided by a deep understanding of PSV epidemiology. Recent large-scale studies have provided critical insights into the risk factors and transmission dynamics of PSV.

1. Age as a Risk Factor: PSV infection is not uniformly distributed across age groups. Multiple studies consistently identify nursery and weaned pigs as having the highest prevalence and viral loads [14, 28, 40, 54]. In Switzerland, PSV was detected much more frequently in fecal samples from weaned and fattening pigs (51-64%) compared to suckling piglets or sows [28]. Similarly, in Zambia, prevalence was 36.2% in suckling pigs but surged to 94% in fattening pigs [40]. This age-dependent pattern suggests that passive maternal immunity wanes, leaving young pigs susceptible. Control strategies, including vaccination of sows to boost passive immunity or targeted vaccination of piglets at weaning, could be particularly effective.

2. Seasonality: A distinct seasonal pattern has been identified, with significantly higher infection rates observed in autumn and winter compared to summer. In Yunnan Province, China, the PSV positive rate was 73.33% in autumn versus only 19% in summer [3]. Similar trends were observed in India, where winter prevalence (30%) was significantly higher than in monsoon (23.3%) and summer (11.1%) [54]. This seasonality may be linked to environmental stability of the virus at lower temperatures and higher humidity, as well as management factors like confinement of animals during colder months. Biosecurity measures should be intensified during these high-risk periods.

3. Co-infection Dynamics: PSV rarely acts alone. The virus is a master of co-infection, frequently found in complex polymicrobial communities. Across multiple studies, high rates of co-infection have been documented with PEDV, PDCoV, PoRV, PKV, PAstV, and PTV [5-7, 28, 32, 38]. In a study of PEDV-positive pigs in the US, 31% were also shedding PSV [38]. In Shanghai, the predominant triple-infection model was PEDV/PKV/PAstV (18.93%), with PEDV/PSV/PAstV also being a common pattern [32]. This complexity suggests that successful control of PSV may require a holistic approach that simultaneously targets multiple pathogens, either through broad-spectrum vaccines or management practices that reduce the overall pathogen load in the environment.

4. Clinical vs. Subclinical Shedding: A critical epidemiological point is the high prevalence of PSV in clinically healthy animals. In Switzerland, PSV was detected in 51% of fecal samples from healthy pigs, compared to 64% from diseased pigs, and statistical analysis found no evidence for an association of virus detection with disease [28]. This finding highlights that PSV is often an "innocent bystander" or an opportunistic pathogen that causes disease primarily in the presence of other stressors or co-infections. Control strategies must therefore account for the fact that healthy carrier animals are a major source of viral shedding, making it difficult to identify infected herds based solely on clinical observation.

In conclusion, the prevention and control of PSV require a comprehensive, scientifically-informed approach that goes beyond simple biosecurity. It mandates a rigorous diagnostic infrastructure to differentiate PSV from other pathogens and to monitor its genetic diversity, the development of DIVA-compatible vaccines tailored to circulating strains, a focus on antiviral and host-directed therapeutics, and the application of epidemiological insights to target interventions where they are most needed. Given the virus's global distribution, high genetic plasticity, and ability to persist in the environment, a coordinated, international effort is required to mitigate its impact on swine health and productivity.

References

[1] Li B, Shi K, Shi Y, Feng S, Yin Y, Lu W, et al.. A Quadruplex RT-qPCR for the Detection of Porcine Sapelovirus, Porcine Kobuvirus, Porcine Teschovirus, and Porcine Enterovirus G. Animals. 2025. DOI: https://doi.org/10.3390/ani15071008

[2] Zhu P, Li Z, Li Z, Meng L, Liu P, Sun X, et al.. First Isolation and Characterization of Three Strains of Porcine Sapelovirus in Yunnan Province, China. Viruses. 2025. DOI: https://doi.org/10.3390/v17040505

[3] Li Z, Tang X, Zhang Z, Zhu P, Li Z, Liu P, et al.. Prevalence and VP1 Gene Evaluation Analysis of Porcine Sapelovirus in Yunnan Province, China, from 2024 to 2025. Viruses. 2025. DOI: https://doi.org/10.3390/v17101336

[4] Zhong Z, Li B, Tao J, Cheng J, Shi Y, Tang P, et al.. Development of an Indirect ELISA to Distinguish between Porcine Sapelovirus-Infected and -Vaccinated Animals Using the Viral Nonstructural Protein 3AB. Current Issues in Molecular Biology. 2024. DOI: https://doi.org/10.3390/cimb46090583

[5] Chen Q, Sun Z, Che Y, Chen R, Wu X, Wu R, et al.. High Prevalence, Genetic Diversity, and Recombination of Porcine Sapelovirus in Pig Farms in Fujian, Southern China. Viruses. 2023. DOI: https://doi.org/10.3390/v15081751

[6] Zhang Y, Li Q, Si L, Gao J, Yuan J, Xia L, et al.. Isolation and Characterization of Porcine Sapelovirus from the PDCoV-Positive Sample and Its Molecular Epidemiology in Henan Province, China. Transboundary and Emerging Diseases. 2023. DOI: https://doi.org/10.1155/2023/9943040

[7] Lu S, Ma M, Yan X, Zhao F, Hu W, Ding Q, et al.. Development and application of a low-priced duplex quantitative PCR assay based on SYBR Green I for the simultaneous detection of porcine deltacoronavirus and porcine sapelovirus. Veterinární Medicína. 2023. DOI: https://doi.org/10.17221/79/2022-VETMED

[8] Ibrahim YM, Zhang W, Werid G, Zhang H, Feng Y, Pan Y, et al.. Isolation, Characterization, and Molecular Detection of Porcine Sapelovirus. Viruses. 2022. DOI: https://doi.org/10.3390/v14020349

[9] Yin M, Wen W, Wang H, Zhao Q, Zhu H, Chen H, et al.. Porcine Sapelovirus 3Cpro Inhibits the Production of Type I Interferon. Frontiers in Cellular and Infection Microbiology. 2022. DOI: https://doi.org/10.3389/fcimb.2022.852473

[10] Chen J, Suo X, Cao L, Yuan C, Shi L, Duan Y, et al.. Virome Analysis for Identification of a Novel Porcine Sapelovirus Isolated in Western China. Microbiology spectrum. 2022. DOI: https://doi.org/10.1128/spectrum.01801-22

[11] Hao C, Ren H, Wu X, Shu X, Li Z, Hu Y, et al.. Preparation of monoclonal antibody and identification of two novel B cell epitopes to VP1 protein of porcine sapelovirus.. Veterinary Microbiology. 2022. DOI: https://doi.org/10.1016/j.vetmic.2022.109593

[12] Mou C, Wang Y, Pan S, Shi K, Chen Z. Porcine sapelovirus 2A protein induces mitochondrial-dependent apoptosis. Frontiers in Immunology. 2022. DOI: https://doi.org/10.3389/fimmu.2022.1050354

[13] Li Y, Du L, Jin T, Cheng Y, Zhang X, Jiao S, et al.. Characterization and epidemiological survey of porcine sapelovirus in China.. Veterinary Microbiology. 2019. DOI: https://doi.org/10.1016/J.VETMIC.2019.02.017

[14] Yang T, Zhang L, Lu Y, Guo M, Zhang Z, Lin A. Characterization of porcine sapelovirus prevalent in western Jiangxi, China. BMC Veterinary Research. 2021. DOI: https://doi.org/10.1186/s12917-021-02979-7

[15] Li N, Tao J, Li B, Cheng J, Shi Y, Shi X, et al.. Molecular characterization of a porcine sapelovirus strain isolated in China. Archives of Virology. 2021. DOI: https://doi.org/10.1007/s00705-021-05153-4

[16] Yang T, Lu Y, Zhang L. Proposed genotype definition of Porcine sapelovirus.. Polish journal of veterinary sciences. 2021. DOI: https://doi.org/10.24425/pjvs.2021.137667

[17] Mouna V, Suresh DKP, Naik N, Manjunatha J, Velankar A, Vijay M, et al.. Codon usage bias and evolutionary dynamics of porcine Sapelovirus: insights into host adaptation. Veterinaria México OA. 2026. DOI: https://doi.org/10.22201/fmvz.24486760e.2026.1480

[18] Kumari S, Ray P, Singh R, Desingu PA, Varshney R, Saikumar G. Pathological and molecular investigation of porcine sapelovirus infection in naturally affected Indian pigs.. Microbial Pathogenesis. 2019. DOI: https://doi.org/10.1016/j.micpath.2018.12.006

[19] Ray P, Desingu PA, Kumari S, John J, Sethi M, Sharma G, et al.. Porcine sapelovirus among diarrhoeic piglets in India.. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12628

[20] Bai H, Liu J, Fang L, Kataoka M, Takeda N, Wakita T, et al.. Characterization of porcine sapelovirus isolated from Japanese swine with PLC/PRF/5 cells. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12796

[21] Chelli E, Sabato LD, Vaccari G, Ostanello F, Bartolo ID. Detection and Characterization of Porcine Sapelovirus in Italian Pig Farms. Animals. 2020. DOI: https://doi.org/10.3390/ani10060966

[22] Piorkowski G, Capai L, Falchi A, Casabianca F, Maestrini O, Gallian P, et al.. First Identification and Genomic Characterization of a Porcine Sapelovirus from Corsica, France, 2017. Microbiology Resource Announcements. 2018. DOI: https://doi.org/10.1128/MRA.01049-18

[23] Kumari S, Ray PK, Singh R, Desingu PA, Sharma GT, Saikumar G. Development of a Taqman-based real-time PCR assay for detection of porcine sapelovirus infection in pigs. Animal Biotechnology. 2018. DOI: https://doi.org/10.1080/10495398.2018.1549561

[24] Zhu H, Li X, Xiong J, Li X, Chen H, Qian P. Isolation and full-genome sequencing of porcine sapelovirus strain in piglets from Hainan province, China. . 2020. DOI: https://doi.org/10.21203/rs.3.rs-16445/v1

[25] Chen Q, Zheng Y, Guo B, Zhang J, Yoon K, Harmon K, et al.. Complete Genome Sequence of Porcine Sapelovirus Strain USA/IA33375/2015 Identified in the United States. Genome Announcements. 2016. DOI: https://doi.org/10.1128/genomeA.01055-16

[26] Donin D, Lemé R, Alfieri A, Alberton G, Alfieri A, Celso R, et al.. Molecular survey of porcine teschovirus, porcine sapelovirus, and enterovirus G in captive wild boars (Sus scrofa scrofa) of. . 2015. DOI: https://doi.org/10.1590/s0100-736x2015000500003

[27] Capai L, Piorkowski G, Maestrini O, Casabianca F, Masse S, Lamballerie XDd, et al.. Detection of porcine enteric viruses (Kobuvirus, Mamastrovirus and Sapelovirus) in domestic pigs in Corsica, France. bioRxiv. 2021. DOI: https://doi.org/10.1371/journal.pone.0260161

[28] Stäubli T, Rickli CI, Torgerson P, Fraefel C, Lechmann J. Porcine teschovirus, sapelovirus, and enterovirus in Swiss pigs: multiplex RT-PCR investigation of viral frequencies and disease association. Journal of Veterinary Diagnostic Investigation. 2021. DOI: https://doi.org/10.1177/10406387211025827

[29] Son K, Kim D, Kwon J, Choi J, Kang M, Belsham G, et al.. Full-Length Genomic Analysis of Korean Porcine Sapelovirus Strains. PLoS ONE. 2014. DOI: https://doi.org/10.1371/journal.pone.0107860

[30] Masuda T, Sunaga F, Naoi Y, Ito M, Takagi H, Katayama Y, et al.. Whole genome analysis of a novel picornavirus related to the Enterovirus/Sapelovirus supergroup from porcine feces in Japan.. Virus Research. 2018. DOI: https://doi.org/10.1016/j.virusres.2018.09.003

[31] Kim S, Park C, Park G, Choe S, Jang M, Lee Y, et al.. Seroprevalence, Genetic Characteristics, and Pathogenicity of Korean Porcine Sapeloviruses. Viruses. 2025. DOI: https://doi.org/10.3390/v17070870

[32] Li B, Tao J, Li X, Cheng J, Shi Y, Tang P, et al.. Relevancy Prediction of the Emerging Pathogens with Porcine Diarrhea by Logistic Regression Model. Microorganisms. 2025. DOI: https://doi.org/10.3390/microorganisms13030528

[33] Boros Á, László Z, Pankovics P, Marosi A, Albert M, Cságola A, et al.. High prevalence, genetic diversity and a potentially novel genotype of Sapelovirus A (Picornaviridae) in enteric and respiratory samples in Hungarian swine farms.. Journal of General Virology. 2020. DOI: https://doi.org/10.1099/jgv.0.001410

[34] V. DS. COLLECTION OF THE STRAINS TESCHOVIRUS A, SAPELOVIRUS A, ENTEROVIRUS G OF THE INSTITUTE OF AGRICULTURAL MICROBIOLOGY AND AGROINDUSTRIAL MANUFACTURE OF THE NAAS. Agriciltural microbiology. 2021. DOI: https://doi.org/10.35868/1997-3004.34.69-85

[35] Arruda PH, Arruda BL, Schwartz KJ, Vannucci FA, Resende T, Rovira A, et al.. Detection of a novel sapelovirus in central nervous tissue of pigs with polioencephalomyelitis in the USA. Transboundary and Emerging Diseases. 2017. DOI: https://doi.org/10.1111/tbed.12621

[36] Malik Y, Bhat S, Vlasova A, Wang F, Touil N, Ghosh S, et al.. Sapelovirus. Emerging and Transboundary Animal Viruses. 2020. DOI: https://doi.org/10.1007/978-981-15-0402-0_14

[37] Tassoni L, Zamperin G, Monne I, Beato MS. Nearly Complete Genome Sequence of a Sapelovirus A Strain Identified in Swine in Italy. Microbiology Resource Announcements. 2019. DOI: https://doi.org/10.1128/MRA.00481-19

[38] Chen Q, Wang L, Zheng Y, Zhang J, Guo B, Yoon K, et al.. Metagenomic analysis of the RNA fraction of the fecal virome indicates high diversity in pigs infected by porcine endemic diarrhea virus in the United States. Virology Journal. 2018. DOI: https://doi.org/10.1186/s12985-018-1001-z

[39] Derevianko S. Antigenic and Pathogenic Properties of the Teschovirus A and Sapelovirus A Strains, Isolated from Pigs and Synanthropic Animals in Ukraine. Mikrobiolohichnyi zhurnal. 2019. DOI: https://doi.org/10.15407/microbiolj81.06.083

[40] Harima H, Kajihara M, Simulundu E, Bwalya EC, Qiu Y, Isono M, et al.. Genetic and Biological Diversity of Porcine Sapeloviruses Prevailing in Zambia. Viruses. 2020. DOI: https://doi.org/10.3390/v12020180

[41] Li Q, Jiang J, Li J, Zhang W, Xin Y, He B, et al.. Complexity of Diarrhea-Associated Viruses in Stunted Pigs Identified by Viral Metagenomics. Transboundary and Emerging Diseases. 2025. DOI: https://doi.org/10.1155/tbed/1974716

[42] Sozzi E, Barbieri I, Lavazza A, Lelli D, Moreno A, Canelli E, et al.. Molecular characterization and phylogenetic analysis of VP1 of porcine enteric picornaviruses isolates in Italy.. Transboundary and Emerging Diseases. 2010. DOI: https://doi.org/10.1111/j.1865-1682.2010.01170.x

[43] Dee S, Bauermann FV, Niederwerder M, Singrey A, Clement T, Lima Md, et al.. Survival of viral pathogens in animal feed ingredients under transboundary shipping models. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0194509

[44] Sawant PM, Kulkarni A, Mane R, Patil R, Lavania M. Metatranscriptomic assessment of diarrhoeic faeces reveals diverse RNA viruses in rotavirus group A infected piglets and calves from India. Frontiers in Cellular and Infection Microbiology. 2023. DOI: https://doi.org/10.3389/fcimb.2023.1258660

[45] Bhatta T, Chamings A, Alexandersen S. Exploring the Cause of Diarrhoea and Poor Growth in 8–11-Week-Old Pigs from an Australian Pig Herd Using Metagenomic Sequencing. Viruses. 2021. DOI: https://doi.org/10.3390/v13081608

[46] Reuter G, Boros Á, Pankovics P, Egyed L. Kobuvirus in Domestic Sheep, Hungary. Emerging Infectious Diseases. 2010. DOI: https://doi.org/10.3201/eid1605.091934

[47] Kim D, Son K, Koo K, Kim J, Alfajaro MM, Park J, et al.. Porcine Sapelovirus Uses α2,3-Linked Sialic Acid on GD1a Ganglioside as a Receptor. Journal of Virology. 2016. DOI: https://doi.org/10.1128/JVI.02449-15

[48] Zhao T, Cui L, Yu X, Zhang Z, Shen X, Hua X. Porcine sapelovirus enters PK-15 cells via caveolae-dependent endocytosis and requires Rab7 and Rab11. Virology. 2019. DOI: https://doi.org/10.1016/j.virol.2019.01.009

[49] Wang C, Yu D, Cui L, Hua X, Yuan C, Sun H, et al.. Rapid and real-time detection of Porcine Sapelovirus by reverse transcription loop-mediated isothermal amplification assay. Journal of Virological Methods. 2014. DOI: https://doi.org/10.1016/j.jviromet.2014.03.011

[50] Zhao T, Cui L, Yu X, Zhang Z, Shen X, Hua X. Entry of sapelovirus into IPEC-J2 cells is dependent on caveolae-mediated endocytosis. Virology Journal. 2019. DOI: https://doi.org/10.1186/s12985-019-1144-6

[51] Patel S, Pathak M, Singh A, Agrawal A, Rana J, Saikumar G. Pathology and Molecular Characterization of Porcine Sapelovirus in Indian Pigs. Indian Journal of Animal Research. 2021. DOI: https://doi.org/10.18805/ijar.b-4739

[52] Zhao T, Cui L, Yu X, Zhang Z, Chen Q, Hua X. Proteome Analysis Reveals Syndecan 1 Regulates Porcine Sapelovirus Replication. International Journal of Molecular Sciences. 2020. DOI: https://doi.org/10.3390/ijms21124386

[53] Kumari S, Saikumar G, Desingu PA, Das T, Singh R. Immunohistochemical detection of naturally occurring porcine Sapelovirus infection in Indian pigs. Journal of immunoassay & immunochemistry. 2019. DOI: https://doi.org/10.1080/15321819.2019.1675695

[54] Kumari S, Singh R, Saikumar G. Epidemiological study of porcine sapelovirus infection in pigs at Bareilly area of Uttar Pradesh, India. Biological rhythm research. 2018. DOI: https://doi.org/10.1080/09291016.2018.1557838

[55] Kumari S, Ray P, Singh R, Saikumar G. Pathogenicity of porcine sapelovirus infection in mice. Indian Journal of Animal Sciences. 2019. DOI: https://doi.org/10.56093/ijans.v89i2.87322

[56] Kim D, Kang M, Son K, Bak G, Park J, Hosmillo M, et al.. Pathogenesis of Korean Sapelovirus A in piglets and chicks. Journal of General Virology. 2016. DOI: https://doi.org/10.1099/jgv.0.000571

[57] Hulst M, Heres L, Honing RWHd, Pelser M, Fox M, Poel WVDvd. Study on inactivation of porcine epidemic diarrhoea virus, porcine sapelovirus 1 and adenovirus in the production and storage of laboratory spray‐dried porcine plasma. Journal of Applied Microbiology. 2019. DOI: https://doi.org/10.1111/jam.14235

[58] Zhang W, Kataoka M, Doan HY, Wu F, Takeda N, Muramatsu M, et al.. Isolation and Characterization of a Subtype 4b of Hepatitis E Virus Using a PLC/PRF/5 cell-derived Cell Line Resistant to Porcine Sapelovirus Infection.. Japanese journal of infectious diseases (Print). 2021. DOI: https://doi.org/10.7883/yoken.JJID.2021.100

[59] Jiang C, He H, Zhang C, Zhang X, Han J, Zhang H, et al.. One-step triplex reverse-transcription PCR detection of porcine epidemic diarrhea virus, porcine sapelovirus, and porcine sapovirus. Journal of Veterinary Diagnostic Investigation. 2019. DOI: https://doi.org/10.1177/1040638719883834

[60] Zhang W, Kataoka M, Doan HY, Wu F, Haga K, Takeda N, et al.. Isolation and Characterization of Mammalian Orthoreoviruses Using a Cell Line Resistant to Sapelovirus Infection.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13655